| Year |
Citation |
Score |
| 2024 |
Chen P, Zhao W, Wang S, Bian Z, Li S, Li W, Tu H, Wen CP, Wu X. Predicting oral and esophageal cancers by one model in a Chinese prospective cohort study. Preventive Medicine. 108119. PMID 39214335 DOI: 10.1016/j.ypmed.2024.108119 |
0.328 |
|
| 2024 |
Ren Y, Wang Q, Xu C, Guo Q, Dai R, Xu X, Zhang Y, Wu M, Wu X, Tu H. Combining Classic and Novel Neutrophil-Related Biomarkers to Identify Non-Small-Cell Lung Cancer. Cancers. 16. PMID 38339264 DOI: 10.3390/cancers16030513 |
0.311 |
|
| 2022 |
Tu H, McQuade JL, Davies MA, Huang M, Xie K, Ye Y, Chow WH, Rodriguez A, Wu X. Body mass index and survival after cancer diagnosis: A pan-cancer cohort study of 114 430 patients with cancer. Innovation (Cambridge (Mass.)). 3: 100344. PMID 36353671 DOI: 10.1016/j.xinn.2022.100344 |
0.309 |
|
| 2022 |
Dicanio M, Giaccherini M, Clay-Gilmour A, Macauda A, Sainz J, Machiela MJ, Rybicka-Ramos M, Norman AD, Tyczyńska A, Chanock SJ, Barington T, Kumar SK, Bhatti P, Cozen W, Brown EE, ... ... Wu X, et al. A pleiotropic variant in DNAJB4 is associated with multiple myeloma risk. International Journal of Cancer. PMID 36082445 DOI: 10.1002/ijc.34278 |
0.375 |
|
| 2022 |
Chen CH, Tsai MK, Lee JH, Lin RT, Hsu CY, Wen C, Wu X, Chu TW, Wen CP. "Sugar-Sweetened Beverages" Is an Independent Risk From Pancreatic Cancer: Based on Half a Million Asian Cohort Followed for 25 Years. Frontiers in Oncology. 12: 835901. PMID 35463371 DOI: 10.3389/fonc.2022.835901 |
0.302 |
|
| 2022 |
Yu Y, Chang K, Chen JS, Bohlender RJ, Fowler J, Zhang D, Huang M, Chang P, Li Y, Wong J, Wang H, Gu J, Wu X, Schildkraut J, Cannon-Albright L, et al. A whole-exome case-control association study to characterize the contribution of rare coding variation to pancreatic cancer risk. Hgg Advances. 3: 100078. PMID 35047863 DOI: 10.1016/j.xhgg.2021.100078 |
0.405 |
|
| 2021 |
Zhu Y, Hu Y, Kong X, Xiao Q, Pan Z, Zheng Z, Wei Y, Ziqiang W, Wang D, Chen J, Chen K, Zheng S, Wang M, Wu X, Ding K, et al. Cohort profile: The National Colorectal Cancer Cohort (NCRCC) study in China. Bmj Open. 11: e051397. PMID 34903541 DOI: 10.1136/bmjopen-2021-051397 |
0.334 |
|
| 2020 |
Glubb DM, Thompson DJ, Aben KK, Alsulimani A, Amant F, Annibali D, Attia J, Barricarte A, Beckmann MW, Berchuck A, Bermisheva M, Bernardini MQ, Bischof K, Bjørge L, Bodelon C, ... ... Wu X, et al. Cross-cancer genome-wide association study of endometrial cancer and epithelial ovarian cancer identifies genetic risk regions associated with risk of both cancers. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 33144283 DOI: 10.1158/1055-9965.EPI-20-0739 |
0.393 |
|
| 2020 |
Dimou NL, Papadimitriou N, Mariosa D, Johansson M, Brennan P, Peters U, Chanock SJ, Purdue M, Bishop DT, Gago-Dominquez M, Giles GG, Moreno V, Platz EA, Tangen CM, Wolk A, ... ... Wu X, et al. Circulating adipokine concentrations and risk of five obesity-related cancers: a Mendelian randomization study. International Journal of Cancer. PMID 33038280 DOI: 10.1002/ijc.33338 |
0.33 |
|
| 2020 |
Zhao H, Shen J, Ye Y, Wu X, Esteva FJ, Tripathy D, Chow WH. Validation of plasma metabolites associated with breast cancer risk among Mexican Americans. Cancer Epidemiology. 69: 101826. PMID 33010726 DOI: 10.1016/j.canep.2020.101826 |
0.313 |
|
| 2020 |
Sun R, Xu M, Li X, Gaynor S, Zhou H, Li Z, Bossé Y, Lam S, Tsao MS, Tardon A, Chen C, Doherty J, Goodman G, Bojesen SE, Landi MT, ... ... Wu X, et al. Integration of multiomic annotation data to prioritize and characterize inflammation and immune-related risk variants in squamous cell lung cancer. Genetic Epidemiology. PMID 32924180 DOI: 10.1002/Gepi.22358 |
0.482 |
|
| 2020 |
Wang Q, Gu J, Wang L, Chang DW, Ye Y, Huang M, Roth JA, Wu X. Genetic associations of T cell cancer immune response-related genes with T cell phenotypes and clinical outcomes of early-stage lung cancer. Journal For Immunotherapy of Cancer. 8. PMID 32764075 DOI: 10.1136/Jitc-2019-000336 |
0.411 |
|
| 2020 |
Belachew AA, Reyes ME, Ye Y, Raju GS, Rodriguez MA, Wu X, Hildebrandt MAT. Patterns of racial/ethnic disparities in baseline health-related quality of life and relationship with overall survival in patients with colorectal cancer. Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation. PMID 32621260 DOI: 10.1007/S11136-020-02565-8 |
0.338 |
|
| 2020 |
Clay-Gilmour AI, Hildebrandt MAT, Brown EE, Hofmann JN, Spinelli JJ, Giles GG, Cozen W, Bhatti P, Wu X, Waller RG, Belachew AA, Robinson DP, Norman AD, Sinnwell JP, Berndt SI, et al. Coinherited genetics of multiple myeloma and its precursor, monoclonal gammopathy of undetermined significance. Blood Advances. 4: 2789-2797. PMID 32569378 DOI: 10.1182/Bloodadvances.2020001435 |
0.369 |
|
| 2020 |
Song H, Dicks EM, Tyrer J, Intermaggio M, Chenevix-Trench G, Bowtell DD, Traficante N, Group A, Brenton J, Goranova T, Hosking K, Piskorz A, van Oudenhove E, Doherty J, Harris HR, ... ... Wu X, et al. Population-based targeted sequencing of 54 candidate genes identifies as a susceptibility gene for high-grade serous ovarian cancer. Journal of Medical Genetics. PMID 32546565 DOI: 10.1136/Jmedgenet-2019-106739 |
0.438 |
|
| 2020 |
Deng Y, Xie K, Logothetis CJ, Thompson TC, Kim J, Huang M, Chang DW, Gu J, Wu X, Ye Y. Genetic Variants in Epithelial Mesenchymal Transition Genes as Predictors of Clinical Outcomes in Localized Prostate Cancer. Carcinogenesis. PMID 32215555 DOI: 10.1093/Carcin/Bgaa026 |
0.352 |
|
| 2020 |
Reuben A, Zhang J, Chiou SH, Gittelman RM, Li J, Lee WC, Fujimoto J, Behrens C, Liu X, Wang F, Quek K, Wang C, Kheradmand F, Chen R, Chow CW, ... ... Wu X, et al. Comprehensive T cell repertoire characterization of non-small cell lung cancer. Nature Communications. 11: 603. PMID 32001676 DOI: 10.1038/S41467-019-14273-0 |
0.316 |
|
| 2019 |
Wang Q, Zhang J, Tu H, Liang D, Chang DW, Ye Y, Wu X. Soluble immune checkpoint-related proteins as predictors of tumor recurrence, survival, and T cell phenotypes in clear cell renal cell carcinoma patients. Journal For Immunotherapy of Cancer. 7: 334. PMID 31783776 DOI: 10.1186/S40425-019-0810-Y |
0.337 |
|
| 2019 |
Kleinstern G, Yan H, Hildebrandt MAT, Vijai J, Berndt SI, Ghesquières H, McKay J, Wang SS, Nieters A, Ye Y, Monnereau A, Brooks-Wilson AR, Lan Q, Melbye M, Jackson RD, ... ... Wu X, et al. Inherited variants at 3q13.33 and 3p24.1 are associated with risk of diffuse large B-cell lymphoma and implicate immune pathways. Human Molecular Genetics. PMID 31600786 DOI: 10.1093/Hmg/Ddz228 |
0.411 |
|
| 2019 |
Jiang X, Finucane HK, Schumacher FR, Schmit SL, Tyrer JP, Han Y, Michailidou K, Lesseur C, Kuchenbaecker KB, Dennis J, Conti DV, Casey G, Gaudet MM, Huyghe JR, Albanes D, ... ... Wu X, et al. Publisher Correction: Shared heritability and functional enrichment across six solid cancers. Nature Communications. 10: 4386. PMID 31548585 DOI: 10.1038/S41467-019-12095-8 |
0.333 |
|
| 2019 |
Shen J, Hernandez D, Ye Y, Wu X, Chow WH, Zhao H. Metabolic hormones and breast cancer risk among Mexican American Women in the Mano a Mano Cohort Study. Scientific Reports. 9: 9989. PMID 31292496 DOI: 10.1038/S41598-019-46429-9 |
0.387 |
|
| 2019 |
Kachuri L, Helby J, Bojesen SE, Christiani DC, Su L, Wu X, Tardón A, Fernández-Tardón G, Field JK, Davies MP, Chen C, Goodman GE, Shepherd FA, Leighl NB, Tsao MS, et al. Investigation of Leukocyte Telomere Length and Genetic Variants in Chromosome 5p15.33 as Prognostic Markers in Lung Cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 28: 1228-1237. PMID 31263055 DOI: 10.1158/1055-9965.Epi-18-1215 |
0.451 |
|
| 2019 |
Laskar RS, Muller DC, Li P, Machiela MJ, Ye Y, Gaborieau V, Foll M, Hofmann JN, Colli L, Sampson JN, Wang Z, Bacq-Daian D, Boland A, Abedi-Ardekani B, Durand G, ... ... Wu X, et al. Sex specific associations in genome wide association analysis of renal cell carcinoma. European Journal of Human Genetics : Ejhg. PMID 31231134 DOI: 10.1038/S41431-019-0455-9 |
0.355 |
|
| 2019 |
Shepshelovich D, Xu W, Lu L, Fares A, Yang P, Christiani D, Zhang J, Shiraishi K, Ryan BM, Chen C, Schwartz AG, Tardon A, Wu X, Schabath MB, Teare MD, et al. Body mass index (BMI), BMI change, and overall survival in small cell and non-small cell lung cancer patients: a pooled analysis of the International Lung Cancer Consortium. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 31163278 DOI: 10.1016/J.Jtho.2019.05.031 |
0.405 |
|
| 2019 |
Hung RJ, Spitz MR, Houlston RS, Schwartz AG, Field JK, Ying J, Li Y, Han Y, Ji X, Chen W, Wu X, Gorlov IP, Na J, de Andrade M, Liu G, et al. Lung Cancer Risk in Never Smokers of European Descent is Associated with Genetic Variation in the 515.33 TERT-CLPTM1L Region. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 31009812 DOI: 10.1016/J.Jtho.2019.04.008 |
0.486 |
|
| 2019 |
Li Y, Xiao X, Bossé Y, Gorlova O, Gorlov I, Han Y, Byun J, Leighl N, Johansen JS, Barnett M, Chen C, Goodman G, Cox A, Taylor F, Woll P, ... ... Wu X, et al. Genetic interaction analysis among oncogenesis-related genes revealed novel genes and networks in lung cancer development. Oncotarget. 10: 1760-1774. PMID 30956756 DOI: 10.18632/Oncotarget.26678 |
0.449 |
|
| 2019 |
Jones CC, Bradford Y, Amos CI, Blot WJ, Chanock SJ, Harris CC, Schwartz AG, Spitz MR, Wiencke JK, Wrensch MR, Wu X, Aldrich MC. Cross-cancer pleiotropic associations with lung cancer risk in African Americans. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 30894353 DOI: 10.1158/1055-9965.Epi-18-0935 |
0.394 |
|
| 2019 |
Zhao H, Shen J, Moore SC, Ye Y, Wu X, Zanetti KA, Esteva FJ, Tripathy D, Chow WH. Breast cancer risk in relation to plasma metabolites among Hispanic and African American women. Breast Cancer Research and Treatment. PMID 30771047 DOI: 10.1007/S10549-019-05165-4 |
0.354 |
|
| 2019 |
Zhu Y, Wei Y, Zhang R, Dong X, Shen S, Zhao Y, Bai J, Albanes D, Caporaso NE, Landi MT, Zhu B, Chanock SJ, Gu F, Lam S, Tsao MS, ... ... Wu X, et al. Elevated platelet count appears to be causally associated with increased risk of lung cancer: A Mendelian randomization analysis. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 30700444 DOI: 10.1158/1055-9965.Epi-18-0356 |
0.418 |
|
| 2019 |
Jiang X, Finucane HK, Schumacher FR, Schmit SL, Tyrer JP, Han Y, Michailidou K, Lesseur C, Kuchenbaecker KB, Dennis J, Conti DV, Casey G, Gaudet MM, Huyghe JR, Albanes D, ... ... Wu X, et al. Shared heritability and functional enrichment across six solid cancers. Nature Communications. 10: 431. PMID 30683880 DOI: 10.1038/S41467-018-08054-4 |
0.461 |
|
| 2019 |
Shen J, Chrisman M, Wu X, Chow WH, Zhao H. Sleep duration and risk of cancer in the Mexican American Mano-a-Mano Cohort. Sleep Health. 5: 78-83. PMID 30670171 DOI: 10.1016/J.Sleh.2018.09.004 |
0.364 |
|
| 2019 |
Wang Q, Gregg JR, Gu J, Ye Y, Chang DW, Davis JW, Thompson TC, Kim J, Logothetis CJ, Wu X. Genetic associations of T cell cancer immune response with tumor aggressiveness in localized prostate cancer patients and disease reclassification in an active surveillance cohort. Oncoimmunology. 8: e1483303. PMID 30546938 DOI: 10.1080/2162402X.2018.1483303 |
0.463 |
|
| 2019 |
Vulimiri SV, Wu X, Baer-Dubowska W, Andrade Md, Detry M, Spitz MR, DiGiovanni J. Analysis of aromatic DNA adducts and 7,8-dihydro-8-oxo-2' deoxyguanosine in lymphocyte DNA from a case-control study of lung cancer involving minority populations Molecular Carcinogenesis. 27: 330. PMID 10747297 DOI: 10.1002/(Sici)1098-2744(200004)27:4<330::Aid-Mc11>3.0.Co;2-E |
0.351 |
|
| 2019 |
Clay-Gilmour AI, Hildebrandt M, Asmann Y, Brown EE, Hofmann JN, Spinelli J, Giles G, Bhatti P, Cozen W, Robinson DP, O'Brien DR, Rajkumar SV, Tian S, Berndt SI, Chanock SJ, ... ... Wu X, et al. Association between a Polygenic Risk Score for Multiple Myeloma Risk and Overall Survival Blood. 134: 4366-4366. DOI: 10.1182/Blood-2019-126088 |
0.405 |
|
| 2019 |
Clay-Gilmour AI, Hildebrandt MA, Camp NJ, Ziv E, Brown EE, Hofmann JN, Spinelli JJ, Giles GG, Bhatti P, Cozen W, Wu X, Robinson DP, Norman AD, Sinnwell JP, Kumar SK, et al. Abstract 2686: Associations between a polygenic risk score and risk of multiple myeloma and its precursor Cancer Research. 79: 2686-2686. DOI: 10.1158/1538-7445.Am2019-2686 |
0.428 |
|
| 2019 |
Chang J, Hu Z, Sun S, Yu H, Wu X, Wang J. P1.04-20 PD-L1 mRNA Derived from Tumor-Educated Platelets Predicts the Clinical Outcome of Immunotherapy in Non-Small Cell Lung Cancer Journal of Thoracic Oncology. 14. DOI: 10.1016/J.Jtho.2019.08.923 |
0.323 |
|
| 2019 |
Chang J, Hu Z, Zou X, Qin S, Wu X, Wang J. P2.09-08 Correlation Between Hormone Receptor Expression and EGFR Gene Mutation in Lung Cancer Patients with Simultaneous Primary Breast Cancer Journal of Thoracic Oncology. 14. DOI: 10.1016/J.Jtho.2019.08.1657 |
0.397 |
|
| 2018 |
Dai J, Li Z, Amos CI, Hung RJ, Tardon A, Andrew A, Chen C, Christiani DC, Albanes D, van der Heijden EHFM, Duell E, Rennert G, James MD, Yuan JM, Field JK, ... ... Wu X, et al. Systematic analyses of regulatory variants in DNase I hypersensitive sites identified two novel lung cancer susceptibility loci. Carcinogenesis. PMID 30590402 DOI: 10.1093/Carcin/Bgy187 |
0.502 |
|
| 2018 |
Zhang Y, Roth JA, Yu H, Ye Y, Xie K, Zhao H, Chang DW, Huang M, Li H, Qu J, Wu X. A 5-MicroRNA Signature Identified from Serum MicroRNA Profiling Predicts Survival in Patients with Advanced Stage Non-Small Cell Lung Cancer. Carcinogenesis. PMID 30428030 DOI: 10.1093/Carcin/Bgy132 |
0.337 |
|
| 2018 |
Carbone M, Amelio I, Affar EB, Brugarolas J, Cannon-Albright LA, Cantley LC, Cavenee WK, Chen Z, Croce CM, Andrea A, Gandara D, Giorgi C, Jia W, Lan Q, Mak TW, ... ... Wu X, et al. Consensus report of the 8 and 9th Weinman Symposia on Gene x Environment Interaction in carcinogenesis: novel opportunities for precision medicine. Cell Death and Differentiation. PMID 30323273 DOI: 10.1038/S41418-018-0213-5 |
0.419 |
|
| 2018 |
Ferreiro-Iglesias A, Lesseur C, McKay J, Hung RJ, Han Y, Zong X, Christiani D, Johansson M, Xiao X, Li Y, Qian DC, Ji X, Liu G, Caporaso N, Scelo G, ... ... Wu X, et al. Fine mapping of MHC region in lung cancer highlights independent susceptibility loci by ethnicity. Nature Communications. 9: 3927. PMID 30254314 DOI: 10.1038/S41467-018-05890-2 |
0.443 |
|
| 2018 |
Gu J, Zhang J, Zheng L, Ajani JA, Wu X, Ye Y. Serum miR-331-3p predicts tumor recurrence in esophageal adenocarcinoma. Scientific Reports. 8: 14006. PMID 30228315 DOI: 10.1038/S41598-018-32282-9 |
0.314 |
|
| 2018 |
Zhang J, Ye Y, Chang DW, Lin SH, Huang M, Tannir NM, Matin S, Karam JA, Wood CG, Chen ZN, Wu X. Global and targeted microRNA expression profiling in clear cell renal cell carcinoma tissues potentially links miR-155-5p and miR-210-3p to both tumorigenesis and recurrence. The American Journal of Pathology. PMID 30201497 DOI: 10.1016/J.Ajpath.2018.07.026 |
0.303 |
|
| 2018 |
Kelemen LE, Earp M, Fridley BL, Chenevix-Trench G, Fasching PA, Beckmann MW, Ekici AB, Hein A, Lambrechts D, Lambrechts S, Van Nieuwenhuysen E, Vergote I, Rossing MA, Doherty JA, ... ... Wu X, et al. rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology. International Journal of Molecular Sciences. 19. PMID 30134598 DOI: 10.3390/Ijms19092473 |
0.409 |
|
| 2018 |
Ji X, Bossé Y, Landi MT, Gui J, Xiao X, Qian D, Joubert P, Lamontagne M, Li Y, Gorlov I, de Biasi M, Han Y, Gorlova O, Hung RJ, Wu X, et al. Identification of susceptibility pathways for the role of chromosome 15q25.1 in modifying lung cancer risk. Nature Communications. 9: 3221. PMID 30104567 DOI: 10.1038/S41467-018-05074-Y |
0.472 |
|
| 2018 |
Kachuri L, Saarela O, Bojesen SE, Davey Smith G, Liu G, Landi MT, Caporaso NE, Christiani DC, Johansson M, Panico S, Overvad K, Trichopoulou A, Vineis P, Scelo G, Zaridze D, ... Wu X, et al. Mendelian Randomization and mediation analysis of leukocyte telomere length and risk of lung and head and neck cancers. International Journal of Epidemiology. PMID 30059977 DOI: 10.1093/Ije/Dyy140 |
0.466 |
|
| 2018 |
Pierzynski JA, Ye Y, Lippman SM, Rodriguez MA, Wu X, Hildebrandt MAT. Socio-demographic, Clinical, and Genetic Determinants of Quality of Life in Lung Cancer Patients. Scientific Reports. 8: 10640. PMID 30006595 DOI: 10.1038/S41598-018-25712-1 |
0.469 |
|
| 2018 |
Earp M, Tyrer JP, Winham SJ, Lin HY, Chornokur G, Dennis J, Aben KKH, Anton-Culver H, Antonenkova N, Bandera EV, Bean YT, Beckmann MW, Bjorge L, Bogdanova N, Brinton LA, ... ... Wu X, et al. Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility. Plos One. 13: e0197561. PMID 29979793 DOI: 10.1371/Journal.Pone.0197561 |
0.488 |
|
| 2018 |
Byun J, Schwartz AG, Lusk C, Wenzlaff AS, de Andrade M, Mandal D, Gaba C, Yang P, You M, Kupert EY, Anderson MW, Han Y, Li Y, Qian D, Stilp A, ... ... Wu X, et al. Genome-Wide Association Study of Familial Lung Cancer. Carcinogenesis. PMID 29924316 DOI: 10.1093/Carcin/Bgy080 |
0.473 |
|
| 2018 |
Zhao H, Chang D, Ye Y, Shen J, Chow WH, Wu X. Associations of blood mitochondrial DNA copy number with social-demographics and cancer risk: results from the Mano-A-Mano Mexican American Cohort. Oncotarget. 9: 25491-25502. PMID 29876003 DOI: 10.18632/Oncotarget.25321 |
0.448 |
|
| 2018 |
Machiela MJ, Hofmann JN, Carreras-Torres R, Brown KM, Johansson M, Wang Z, Foll M, Li P, Rothman N, Savage SA, Gaborieau V, McKay JD, Ye Y, Henrion M, Bruinsma F, ... ... Wu X, et al. Corrigendum re "Genetic Variants Related to Longer Telomere Length are Associated with Increased Risk of Renal Cell Carcinoma" [Eur Urol 2017;72:747-54]. European Urology. PMID 29853305 DOI: 10.1016/J.Eururo.2018.05.017 |
0.346 |
|
| 2018 |
Sen S, Kato S, Agarwal R, Piha-Paul S, Hess K, Karp D, Janku F, Fu S, Naing A, Pant S, Falchook G, Tang C, Wu X, Ye Y, Tsimberidou A, et al. Phase I study of nab-paclitaxel, gemcitabine, and bevacizumab in patients with advanced cancers. British Journal of Cancer. PMID 29695765 DOI: 10.1038/S41416-018-0068-Z |
0.305 |
|
| 2018 |
Shu X, Gu J, Huang M, Tannir NM, Matin SF, Karam JA, Wood CG, Wu X, Ye Y. Germline genetic variants in somatically significantly mutated genes in tumors are associated with renal cell carcinoma risk and outcome. Carcinogenesis. PMID 29635281 DOI: 10.1093/Carcin/Bgy021 |
0.485 |
|
| 2018 |
Lian J, Lin SH, Ye Y, Chang DW, Huang M, Dinney CP, Wu X. Serum microRNAs as predictors of risk for non-muscle invasive bladder cancer. Oncotarget. 9: 14895-14908. PMID 29599914 DOI: 10.18632/Oncotarget.24473 |
0.364 |
|
| 2018 |
Khodadadi-Jamayran A, Akgol-Oksuz B, Afanasyeva Y, Heguy A, Thompson M, Ray K, Giro-Perafita A, Sánchez I, Wu X, Tripathy D, Zeleniuch-Jacquotte A, Tsirigos A, Esteva FJ. Prognostic role of elevated mir-24-3p in breast cancer and its association with the metastatic process. Oncotarget. 9: 12868-12878. PMID 29560116 DOI: 10.18632/Oncotarget.24403 |
0.362 |
|
| 2018 |
Dixon-Suen SC, Nagle CM, Thrift AP, Pharoah PDP, Ewing A, Pearce CL, Zheng W, Chenevix-Trench G, Fasching PA, Beckmann MW, Lambrechts D, Vergote I, Lambrechts S, Van Nieuwenhuysen E, ... ... Wu X, et al. Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study. British Journal of Cancer. PMID 29555990 DOI: 10.1038/S41416-018-0011-3 |
0.464 |
|
| 2018 |
Sepesi B, Ye Y, Mitchell KG, Zhang L, Gu J, Ji L, Antonoff MB, Hofstetter WL, Rice DC, Mehran RJ, Walsh GL, Vaporciyan AA, Swisher SG, Roth JA, Wu X. Genetic variants in cytokine signaling pathways and clinical outcomes in early-stage lung cancer patients. The Journal of Thoracic and Cardiovascular Surgery. PMID 29548588 DOI: 10.1016/J.Jtcvs.2018.02.015 |
0.44 |
|
| 2018 |
Tu H, Dinney CP, Ye Y, Grossman HB, Lerner SP, Wu X. Is folic acid safe for non-muscle-invasive bladder cancer patients? An evidence-based cohort study. The American Journal of Clinical Nutrition. 107: 208-216. PMID 29529165 DOI: 10.1093/Ajcn/Nqx019 |
0.369 |
|
| 2018 |
Tu H, Wen CP, Tsai SP, Chow WH, Wen C, Ye Y, Zhao H, Tsai MK, Huang M, Dinney CP, Tsao CK, Wu X. Cancer risk associated with chronic diseases and disease markers: prospective cohort study. Bmj (Clinical Research Ed.). 360: k134. PMID 29386192 DOI: 10.1136/Bmj.K134 |
0.391 |
|
| 2018 |
Reuben A, Gittelman R, Zhang J, Quek K, Vence LM, Behrens C, Chen R, Fujimoto J, Chow C, Wu X, Allison JP, Sharma P, Zhang J, Lee JJ, Sepesi B, et al. Association of the T-cell receptor landscape with survival in non-small cell lung cancer. Journal of Clinical Oncology. 36: 140-140. DOI: 10.1200/Jco.2018.36.5_Suppl.140 |
0.338 |
|
| 2018 |
Tu H, Dinney CP, Ye Y, Grossman BH, Lerner SP, Wu X. Abstract 2239: Is folic acid safe for non-muscle-invasive bladder cancer patients? An evidence-based cohort study Cancer Research. 78: 2239-2239. DOI: 10.1158/1538-7445.Am2018-2239 |
0.427 |
|
| 2018 |
Kleinstern G, Hildebrand M, Joseph V, Berndt SI, Ghesquières H, McKay J, Wang SS, Nieters A, Cox D, Monnereau A, Brooks-Wilson AR, Lan Q, Melbye M, Jackson RD, Teras LR, ... ... Wu X, et al. Abstract 221: Inherited variants at 3q13.33 and 3p24.1 influences risk of diffuse large B-cell lymphoma Epidemiology. DOI: 10.1158/1538-7445.Am2018-221 |
0.302 |
|
| 2017 |
Westhoff E, Wu X, Kiemeney LA, Lerner SP, Ye Y, Huang M, Dinney CP, Vrieling A, Tu H. Dietary patterns and risk of recurrence and progression in non-muscle-invasive bladder cancer. International Journal of Cancer. PMID 29235103 DOI: 10.1002/Ijc.31214 |
0.419 |
|
| 2017 |
Zhao H, Han L, Chang D, Ye Y, Shen J, Daniel CR, Gu J, Chow WH, Wu X. Social-demographics, health behaviors, and telomere length in the Mexican American Mano a Mano Cohort. Oncotarget. 8: 96553-96567. PMID 29228552 DOI: 10.18632/Oncotarget.19903 |
0.361 |
|
| 2017 |
Han Y, Xu J, Kim J, Wu X, Gu J. LINE-1 methylation in peripheral blood leukocytes and clinical characteristics and prognosis of prostate cancer patients. Oncotarget. 8: 94020-94027. PMID 29212206 DOI: 10.18632/Oncotarget.21511 |
0.39 |
|
| 2017 |
Williams SB, Kamat AM, Mmeje C, Ye Y, Huang M, Chang DW, Dinney CP, Wu X. Genetic variants in the inflammation pathway as predictors of recurrence and progression in non-muscle invasive bladder cancer treated with Bacillus Calmette-Guérin. Oncotarget. 8: 88782-88791. PMID 29179475 DOI: 10.18632/Oncotarget.21222 |
0.483 |
|
| 2017 |
Shen J, Ye Y, Chang DW, Huang M, Heymach JV, Roth JA, Wu X, Zhao H. Circulating metabolite profiles to predict overall survival in advanced non-small cell lung cancer patients receiving first-line chemotherapy. Lung Cancer (Amsterdam, Netherlands). 114: 70-78. PMID 29173770 DOI: 10.1016/J.Lungcan.2017.10.018 |
0.372 |
|
| 2017 |
Ferdosi S, Rehder DS, Maranian P, Castle EP, Ho TH, Pass HI, Cramer DW, Anderson KS, Fu L, Cole DEC, Le T, Wu X, Borges CR. Stage Dependence, Cell-Origin Independence and Prognostic Capacity of Serum Glycan Fucosylation, β1-4 Branching, β1-6 Branching and α2-6 Sialylation in Cancer. Journal of Proteome Research. PMID 29129073 DOI: 10.1021/Acs.Jproteome.7B00672 |
0.403 |
|
| 2017 |
Zhang J, Raju GS, Chang DW, Lin SH, Chen Z, Wu X. Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer. Cancer. PMID 29112225 DOI: 10.1002/Cncr.31062 |
0.349 |
|
| 2017 |
Lin M, Zhang L, Hildebrandt MAT, Huang M, Wu X, Ye Y. Common, germline genetic variations in the novel tumor suppressor BAP1 and risk of developing different types of cancer. Oncotarget. 8: 74936-74946. PMID 29088836 DOI: 10.18632/Oncotarget.20465 |
0.532 |
|
| 2017 |
Feng Y, Wang Y, Liu H, Liu Z, Mills C, Owzar K, Xie J, Han Y, Qian DC, Rj RJH, Brhane Y, McLaughlin J, Brennan P, Bickeböller H, Rosenberger A, ... ... Wu X, et al. Novel Genetic Variants in the P38MAPK Pathway Gene ZAK and Susceptibility to Lung Cancer. Molecular Carcinogenesis. PMID 29071797 DOI: 10.1002/Mc.22748 |
0.495 |
|
| 2017 |
Li Y, Xiao X, Han Y, Gorlova O, Qian D, Leighl N, Johansen JS, Barnett M, Chen C, Goodman G, Cox A, Taylor F, Woll P, Wichmann HE, Manz J, ... ... Wu X, et al. Genome-wide interaction study of smoking behavior and non-small cell lung cancer risk in Caucasian population. Carcinogenesis. PMID 29059373 DOI: 10.1093/Carcin/Bgx113 |
0.476 |
|
| 2017 |
Zhu J, Tu H, Matin SF, Tannir NM, Wood CG, Wu X. Glycemic Index, Glycemic Load, and Carbohydrate Intake in Association with Risk of Renal Cell Carcinoma. Carcinogenesis. PMID 28968893 DOI: 10.1093/Carcin/Bgx083 |
0.364 |
|
| 2017 |
Xie K, Ye Y, Zeng Y, Gu J, Yang H, Wu X. Polymorphisms in Genes Related to Epithelial-Mesenchymal Transition and Risk of Non-Small Cell Lung Cancer. Carcinogenesis. PMID 28968839 DOI: 10.1093/Carcin/Bgx079 |
0.518 |
|
| 2017 |
Wang T, Moon JY, Wu Y, Amos CI, Hung RJ, Tardon A, Andrew A, Chen C, Christiani DC, Albanes D, Heijden EHFMV, Duell E, Rennert G, Goodman G, Liu G, ... ... Wu X, et al. Pleiotropy of genetic variants on obesity and smoking phenotypes: Results from the Oncoarray Project of The International Lung Cancer Consortium. Plos One. 12: e0185660. PMID 28957450 DOI: 10.1371/Journal.Pone.0185660 |
0.38 |
|
| 2017 |
Zhang L, Lin J, Ye Y, Oba T, Gentile E, Lian J, Wang J, Zhao Y, Gu J, Wistuba II, Roth JA, Ji L, Wu X. Serum microRNA-150 predicts prognosis for early-stage non-small cell lung cancer and promotes tumor cell proliferation by targeting tumor suppressor gene SRCIN1. Clinical Pharmacology and Therapeutics. PMID 28891208 DOI: 10.1002/Cpt.870 |
0.316 |
|
| 2017 |
Han Y, Xu J, Kim J, Wu X, Gu J. Methylation of subtelomeric repeat D4Z4 in peripheral blood leukocytes is associated with biochemical recurrence in localized prostate cancer patients. Carcinogenesis. 38: 821-826. PMID 28854562 DOI: 10.1093/Carcin/Bgx064 |
0.341 |
|
| 2017 |
Hildebrandt MAT, Reyes M, Wu X, Pu X, Thompson KA, Ma J, Landstrom AP, Morrison AC, Ater JL. Hypertension Susceptibility Loci are Associated with Anthracycline-related Cardiotoxicity in Long-term Childhood Cancer Survivors. Scientific Reports. 7: 9698. PMID 28851949 DOI: 10.1038/S41598-017-09517-2 |
0.472 |
|
| 2017 |
Lin J, Zandi R, Shao R, Gu J, Ye Y, Wang J, Zhao Y, Pertsemlidis A, Wistuba II, Wu X, Roth JA, Ji L. A miR-SNP biomarker linked to an increased lung cancer survival by miRNA-mediated down-regulation of FZD4 expression and Wnt signaling. Scientific Reports. 7: 9029. PMID 28831115 DOI: 10.1038/S41598-017-09604-4 |
0.345 |
|
| 2017 |
Machiela MJ, Hofmann JN, Carreras-Torres R, Brown KM, Johansson M, Wang Z, Foll M, Li P, Rothman N, Savage SA, Gaborieau V, McKay JD, Ye Y, Henrion M, Bruinsma F, ... ... Wu X, et al. Genetic Variants Related to Longer Telomere Length are Associated with Increased Risk of Renal Cell Carcinoma. European Urology. PMID 28797570 DOI: 10.1016/J.Eururo.2017.07.015 |
0.332 |
|
| 2017 |
Long Y, Sanchez-Espiridion B, Lin M, White L, Mishra L, Raju GS, Kopetz S, Eng C, Hildebrandt MAT, Chang DW, Ye Y, Liang D, Wu X. Global and targeted serum metabolic profiling of colorectal cancer progression. Cancer. PMID 28640361 DOI: 10.1002/Cncr.30829 |
0.377 |
|
| 2017 |
Shu X, Purdue MP, Ye Y, Tu H, Wood CG, Tannir NM, Wang Z, Albanes D, Gapstur SM, Stevens VL, Rothman N, Chanock SJ, Wu X. Potential Susceptibility Loci Identified for Renal Cell Carcinoma by Targeting Obesity-related Genes. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 28626070 DOI: 10.1158/1055-9965.Epi-17-0141 |
0.311 |
|
| 2017 |
McKay JD, Hung RJ, Han Y, Zong X, Carreras-Torres R, Christiani DC, Caporaso NE, Johansson M, Xiao X, Li Y, Byun J, Dunning A, Pooley KA, Qian DC, Ji X, ... ... Wu X, et al. Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes. Nature Genetics. PMID 28604730 DOI: 10.1038/Ng.3892 |
0.464 |
|
| 2017 |
Carreras-Torres R, Johansson M, Haycock PC, Wade KH, Relton CL, Martin RM, Davey Smith G, Albanes D, Aldrich MC, Andrew A, Arnold SM, Bickeböller H, Bojesen SE, Brunnström H, Manjer J, ... ... Wu X, et al. Obesity, metabolic factors and risk of different histological types of lung cancer: A Mendelian randomization study. Plos One. 12: e0177875. PMID 28594918 DOI: 10.1371/Journal.Pone.0177875 |
0.418 |
|
| 2017 |
Chen Y, Hao D, Wu X, Xing W, Yang Y, He C, Wang W, Liu J, Wang J. Neoadjuvant versus adjuvant chemoradiation for stage II-III esophageal squamous cell carcinoma: a single institution experience. Diseases of the Esophagus : Official Journal of the International Society For Diseases of the Esophagus. 30: 1-7. PMID 28475725 DOI: 10.1093/Dote/Dox016 |
0.322 |
|
| 2017 |
Tu H, Gu J, Meng QH, Kim J, Strom S, Davis JW, He Y, Wagar EA, Thompson TC, Logothetis CJ, Wu X. Low serum testosterone is associated with tumor aggressiveness and poor prognosis in prostate cancer. Oncology Letters. 13: 1949-1957. PMID 28454349 DOI: 10.3892/Ol.2017.5616 |
0.397 |
|
| 2017 |
Zhang L, Ye Y, Tu H, Hildebrandt MA, Zhao L, Heymach JV, Roth JA, Wu X. MicroRNA-related genetic variants in iron regulatory genes, dietary iron intake, microRNAs and lung cancer risk. Annals of Oncology : Official Journal of the European Society For Medical Oncology. 28: 1124-1129. PMID 28453699 DOI: 10.1093/Annonc/Mdx046 |
0.365 |
|
| 2017 |
Feng Y, Wang Y, Liu H, Liu Z, Mills C, Han Y, Hung RJ, Brhane Y, McLaughlin J, Brennan P, Bickeboeller H, Rosenberger A, Houlston RS, Caporaso NE, Teresa Landi M, ... ... Wu X, et al. Genetic variants of PTPN2 are associated with lung cancer risk: a re-analysis of eight GWASs in the TRICL-ILCCO consortium. Scientific Reports. 7: 825. PMID 28400551 DOI: 10.1038/S41598-017-00850-0 |
0.506 |
|
| 2017 |
Zhang Y, Zhang L, Li R, Chang DW, Ye Y, Minna JD, Roth JA, Han B, Wu X. Genetic variations in cancer-related significantly mutated genes and lung cancer susceptibility. Annals of Oncology : Official Journal of the European Society For Medical Oncology. PMID 28383694 DOI: 10.1093/Annonc/Mdx161 |
0.438 |
|
| 2017 |
Liu H, Liu Z, Wang Y, Stinchcombe TE, Owzar K, Han Y, Hung RJ, Brhane Y, McLaughlin J, Brennan P, Bickeböller H, Rosenberger A, Houlston RS, Caporaso N, Landi MT, ... ... Wu X, et al. Functional variants in DCAF4 associated with lung cancer risk in European populations. Carcinogenesis. PMID 28383684 DOI: 10.1093/Carcin/Bgx033 |
0.485 |
|
| 2017 |
Wang Y, McKay JD, Rafnar T, Wang Z, Timofeeva MN, Broderick P, Zong X, Laplana M, Wei Y, Han Y, Lloyd A, Delahaye-Sourdeix M, Chubb D, Gaborieau V, Wheeler W, ... ... Wu X, et al. Corrigendum: Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer. Nature Genetics. 49: 651. PMID 28358128 DOI: 10.1038/Ng0417-651A |
0.469 |
|
| 2017 |
Qu K, Gu J, Ye Y, Williams SB, Dinney CP, Wu X, Kamat A. High baseline levels of interleukin-8 in leukocytes and urine predict tumor recurrence in non-muscle invasive bladder cancer patients receiving bacillus Calmette-Guerin therapy: A long-term survival analysis. Oncoimmunology. 6: e1265719. PMID 28344874 DOI: 10.1080/2162402X.2016.1265719 |
0.303 |
|
| 2017 |
Pan Y, Liu H, Wang Y, Kang X, Liu Z, Owzar K, Han Y, Su L, Wei Y, Hung RJ, Brhane Y, McLaughlin J, Brennan P, Bickeböller H, Rosenberger A, ... ... Wu X, et al. Associations between genetic variants in mRNA splicing-related genes and risk of lung cancer: a pathway-based analysis from published GWASs. Scientific Reports. 7: 44634. PMID 28304396 DOI: 10.1038/Srep44634 |
0.476 |
|
| 2017 |
Zhao L, Chang DW, Gong Y, Eng C, Wu X. Measurement of DNA damage in peripheral blood by the γ-H2AX assay as predictor of colorectal cancer risk. Dna Repair. PMID 28291710 DOI: 10.1016/J.Dnarep.2017.03.001 |
0.43 |
|
| 2017 |
Sun Y, Tao W, Huang M, Wu X, Gu J. Genetic variants in telomere-maintenance genes are associated with ovarian cancer risk and outcome. Journal of Cellular and Molecular Medicine. 21: 510-518. PMID 28233473 DOI: 10.1111/Jcmm.12995 |
0.531 |
|
| 2017 |
Li R, Gu J, Heymach JV, Shu X, Zhao L, Han B, Ye Y, Roth J, Wu X. Hypoxia pathway genetic variants predict survival of non-small-cell lung cancer patients receiving platinum-based chemotherapy. Carcinogenesis. PMID 28186269 DOI: 10.1093/Carcin/Bgx014 |
0.449 |
|
| 2017 |
Toth R, Scherer D, Kelemen LE, Risch A, Hazra A, Balavarca Y, Issa JJ, Moreno V, Eeles RA, Ogino S, Wu X, Ye Y, Hung RJ, Goode EL, Ulrich CM. Genetic Variants in Epigenetic Pathways and Risks of Multiple Cancers in the GAME-ON Consortium. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 28115406 DOI: 10.1158/1055-9965.Epi-16-0728 |
0.628 |
|
| 2017 |
Gu J, Liang D, Pierzynski JA, Zheng L, Ye Y, Zhang J, Ajani JA, Wu X. D-mannose: a Novel Prognostic Biomarker for Patients with Esophageal Adenocarcinoma. Carcinogenesis. PMID 28062409 DOI: 10.1093/Carcin/Bgw207 |
0.354 |
|
| 2017 |
Wu X, Ye Y, Barcenas CH, Chow W, Meng QH, Gregor MCM, Hildebrandt M, Zhao H, Gu X, Deng Y, Wagar EA, Esteva FJ, Tripathy D, Hortobagyi GN. Abstract LB-165: Personalized prognostic prediction models for breast cancer recurrence and survival incorporating multidimensional data Cancer Research. 77. DOI: 10.1158/1538-7445.Am2017-Lb-165 |
0.379 |
|
| 2017 |
Hildebrandt MAT, Belachew AA, Reyes ME, Ye Y, Wu X. Abstract 990: Patterns of racial disparities in health-related quality of life among colorectal cancer patients and relationship with survival Cancer Research. 77: 990-990. DOI: 10.1158/1538-7445.Am2017-990 |
0.329 |
|
| 2017 |
Tu H, Sun L, Dong X, Gong Y, Xu Q, Jing J, Bostick RM, Wu X, Yuan Y. Abstract 5304: A serological biopsy using five stomach-specific circulating biomarkers for gastric cancer risk assessment: a multi-phase study Cancer Research. 77: 5304-5304. DOI: 10.1158/1538-7445.Am2017-5304 |
0.418 |
|
| 2017 |
Daniel CR, Hoffman KL, Raju GS, Hanash SM, Hutchinson DS, Ajami NJ, Fowler RG, Browman GJ, Sood A, Scheet P, Wu X, Petrosino JF. Abstract 238: Evidence of early colorectal cancer risk and prevention pathways in the fecal microbiome of colonoscopy patients: associations with diet and circulating adipocytokines Cancer Research. 77: 238-238. DOI: 10.1158/1538-7445.Am2017-238 |
0.437 |
|
| 2017 |
Kachuri L, Johansson M, Brennan P, Haycock P, Liu G, Landi MT, Christiani DC, Caporaso NE, Wu X, Aldrich MC, Albanes D, Tardón A, Rennert G, Chen C, Goodman GE, et al. Abstract 2292: Lung function and lung cancer risk: a Mendelian randomization study of UK Biobank cohort and the International Lung Cancer Consortium Epidemiology. 77: 2292-2292. DOI: 10.1158/1538-7445.Am2017-2292 |
0.42 |
|
| 2017 |
Zhang L, Zhang Y, Li R, Chang DW, Ye Y, Minna JD, Roth JA, Han B, Wu X. Abstract 1275: Genetic variations in cancer-related significantly mutated genes and lung cancer susceptibility Epidemiology. 77: 1275-1275. DOI: 10.1158/1538-7445.Am2017-1275 |
0.448 |
|
| 2016 |
Takahashi K, Wang F, Kantarjian H, Doss D, Khanna K, Thompson E, Zhao L, Patel K, Neelapu S, Gumbs C, Bueso-Ramos C, DiNardo CD, Colla S, Ravandi F, Zhang J, ... ... Wu X, et al. Preleukaemic clonal haemopoiesis and risk of therapy-related myeloid neoplasms: a case-control study. The Lancet. Oncology. PMID 27923552 DOI: 10.1016/S1470-2045(16)30626-X |
0.38 |
|
| 2016 |
Permuth JB, Reid B, Earp M, Chen YA, Monteiro AN, Chen Z, Aocs Study Group, Chenevix-Trench G, Fasching PA, Beckmann MW, Lambrechts D, Vanderstichele A, Van Niewenhuyse E, Vergote I, Rossing MA, ... ... Wu X, et al. Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility: results from a large-scale collaboration. Oncotarget. 7: 72381-72394. PMID 27911851 DOI: 10.18632/Oncotarget.10546 |
0.424 |
|
| 2016 |
Zhou F, Wang Y, Liu H, Ready N, Han Y, Hung RJ, Brhane Y, McLaughlin J, Brennan P, Bickeböller H, Rosenberger A, Houlston RS, Caporaso N, Landi MT, Brüske I, ... ... Wu X, et al. Susceptibility loci of CNOT6 in the general mRNA degradation pathway and lung cancer risk - a re-analysis of eight GWASs. Molecular Carcinogenesis. PMID 27805284 DOI: 10.1002/Mc.22585 |
0.455 |
|
| 2016 |
Wu X, Wen CP, Ye Y, Tsai M, Wen C, Roth JA, Pu X, Chow WH, Huff C, Cunningham S, Huang M, Wu S, Tsao CK, Gu J, Lippman SM. Personalized Risk Assessment in Never, Light, and Heavy Smokers in a prospective cohort in Taiwan. Scientific Reports. 6: 36482. PMID 27805040 DOI: 10.1038/srep36482 |
0.33 |
|
| 2016 |
Chen M, Rothman N, Ye Y, Gu J, Scheet PA, Huang M, Chang DW, Dinney CP, Silverman DT, Figueroa JD, Chanock SJ, Wu X. Pathway analysis of bladder cancer genome-wide association study identifies novel pathways involved in bladder cancer development. Genes & Cancer. 7: 229-239. PMID 27738493 DOI: 10.18632/Genesandcancer.113 |
0.509 |
|
| 2016 |
Southey MC, Goldgar DE, Winqvist R, Pylkäs K, Couch F, Tischkowitz M, Foulkes WD, Dennis J, Michailidou K, van Rensburg EJ, Heikkinen T, Nevanlinna H, Hopper JL, Dörk T, Claes KB, ... ... Wu X, et al. PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS. Journal of Medical Genetics. PMID 27595995 DOI: 10.1136/jmedgenet-2016-103839 |
0.315 |
|
| 2016 |
Ong JS, Cuellar-Partida G, Lu Y, Ovarian Cancer Study A, Fasching PA, Hein A, Burghaus S, Beckmann MW, Lambrechts D, Van Nieuwenhuysen E, Vergote I, Vanderstichele A, Anne Doherty J, Anne Rossing M, Chang-Claude J, ... ... Wu X, et al. Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization study. International Journal of Epidemiology. PMID 27594614 DOI: 10.1093/Ije/Dyw207 |
0.399 |
|
| 2016 |
Li R, Huang J, Ma M, Lou Y, Zhang Y, Wu L, Chang DW, Zhao P, Dong Q, Wu X, Han B. Two-stage induced differentiation of OCT4+/Nanog+ stem-like cells in lung adenocarcinoma. Oncotarget. PMID 27588392 DOI: 10.18632/Oncotarget.11721 |
0.328 |
|
| 2016 |
Chen LS, Baker T, Hung RJ, Horton A, Culverhouse R, Hartz S, Saccone N, Cheng I, Deng B, Han Y, Hansen HM, Horsman J, Kim C, Rosenberger A, Aben KK, ... ... Wu X, et al. Genetic Risk Can Be Decreased: Quitting Smoking Decreases and Delays Lung Cancer for Smokers With High and Low CHRNA5 Risk Genotypes - A Meta-Analysis. Ebiomedicine. 11: 219-226. PMID 27543155 DOI: 10.1016/J.Ebiom.2016.08.012 |
0.454 |
|
| 2016 |
Hampras SS, Sucheston-Campbell LE, Cannioto R, Chang-Claude J, Modugno F, Dörk T, Hillemanns P, Preus L, Knutson KL, Wallace PK, Hong CC, Friel G, Davis W, Nesline M, Pearce CL, ... ... Wu X, et al. Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer. Oncotarget. PMID 27533245 DOI: 10.18632/Oncotarget.10215 |
0.426 |
|
| 2016 |
Shu X, Ye Y, Gu J, He Y, Davis JW, Thompson TC, Logothetis CJ, Kim J, Wu X. Genetic variants of the Wnt signaling pathway as predictors of aggressive disease and reclassification in men with early stage prostate cancer on active surveillance. Carcinogenesis. PMID 27515962 DOI: 10.1093/Carcin/Bgw082 |
0.443 |
|
| 2016 |
Reyes ME, Ye Y, Zhou Y, Liang A, Kopetz S, Rodriquez MA, Wu X, Hildebrandt MA. Predictors of health-related quality of life and association with survival may identify colorectal cancer patients at high risk of poor prognosis. Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation. PMID 27492454 DOI: 10.1007/S11136-016-1381-8 |
0.377 |
|
| 2016 |
Chen J, Wu X, Huang Y, Chen W, Brand RE, Killary AM, Sen S, Frazier ML. Identification of genetic variants predictive of early onset pancreatic cancer through a population science analysis of functional genomic datasets. Oncotarget. PMID 27486767 DOI: 10.18632/Oncotarget.10924 |
0.398 |
|
| 2016 |
Xie H, Tao W, Wu X, Gu J. Genetic variations in apoptosis pathway and the risk of ovarian cancer. Oncotarget. PMID 27462919 DOI: 10.18632/Oncotarget.10772 |
0.387 |
|
| 2016 |
Dixon SC, Nagle CM, Thrift AP, Pharoah PD, Pearce CL, Zheng W, Painter JN, Chenevix-Trench AG, Fasching PA, Beckmann MW, Lambrechts D, Vergote I, Lambrechts S, Van Nieuwenhuysen E, Rossing MA, ... ... Wu X, et al. Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study. International Journal of Epidemiology. PMID 27401727 DOI: 10.1093/Ije/Dyw158 |
0.463 |
|
| 2016 |
Zanetti KA, Wang Z, Aldrich M, Amos CI, Blot WJ, Bowman ED, Burdette L, Cai Q, Caporaso N, Chung CC, Gillanders EM, Haiman CA, Hansen HM, Henderson BE, Kolonel LN, ... ... Wu X, et al. Genome-wide association study confirms lung cancer susceptibility loci on chromosomes 5p15 and 15q25 in an African-American population. Lung Cancer (Amsterdam, Netherlands). 98: 33-42. PMID 27393504 DOI: 10.1016/J.Lungcan.2016.05.008 |
0.441 |
|
| 2016 |
Wu X, Gu J. Heritability of prostate cancer: a tale of rare variants and common single nucleotide polymorphisms. Annals of Translational Medicine. 4: 206. PMID 27294245 DOI: 10.21037/Atm.2016.05.31 |
0.429 |
|
| 2016 |
Tu H, Heymach JV, Wen CP, Ye Y, Pierzynski JA, Roth JA, Wu X. Different dietary patterns and reduction of lung cancer risk: A large case-control study in the U.S. Scientific Reports. 6: 26760. PMID 27230571 DOI: 10.1038/Srep26760 |
0.5 |
|
| 2016 |
Zhao H, Wilkinson A, Shen J, Wu X, Chow WH. Genetic polymorphisms in genes related to risk-taking behaviours predicting body mass index trajectory among Mexican American adolescents. Pediatric Obesity. PMID 27228958 DOI: 10.1111/Ijpo.12151 |
0.326 |
|
| 2016 |
Scelo G, Hofmann JN, Banks RE, Bigot P, Bhatt RS, Cancel-Tassin G, Chew SK, Creighton CJ, Cussenot O, Davis IJ, Escudier B, Frayling TM, Häggström C, Hildebrandt MA, Holcatova I, ... ... Wu X, et al. International cancer seminars - A focus on kidney cancer. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. PMID 27130845 DOI: 10.1093/Annonc/Mdw186 |
0.41 |
|
| 2016 |
Chen J, Raju GS, Jogunoori W, Menon V, Majumdar A, Chen JS, Gi YJ, Jeong YS, Phan L, Belkin M, Gu S, Kundra S, Mistry NA, Zhang J, Su X, ... ... Wu X, et al. Mutational Profiles Reveal an Aberrant TGF-β-CEA Regulated Pathway in Colon Adenomas. Plos One. 11: e0153933. PMID 27100181 DOI: 10.1371/Journal.Pone.0153933 |
0.33 |
|
| 2016 |
Cuellar-Partida G, Lu Y, Dixon SC, Fasching PA, Hein A, Burghaus S, Beckmann MW, Lambrechts D, Van Nieuwenhuysen E, Vergote I, Vanderstichele A, Doherty JA, Rossing MA, Chang-Claude J, ... ... Wu X, et al. Assessing the genetic architecture of epithelial ovarian cancer histological subtypes. Human Genetics. PMID 27075448 DOI: 10.1007/S00439-016-1663-9 |
0.396 |
|
| 2016 |
Zhou W, Machiela MJ, Freedman ND, Rothman N, Malats N, Dagnall C, Caporaso N, Teras LT, Gaudet MM, Gapstur SM, Stevens VL, Jacobs KB, Sampson J, Albanes D, Weinstein S, ... ... Wu X, et al. Mosaic loss of chromosome Y is associated with common variation near TCL1A. Nature Genetics. PMID 27064253 DOI: 10.1038/Ng.3545 |
0.497 |
|
| 2016 |
Machiela MJ, Lan Q, Slager SL, Vermeulen RC, Teras LR, Camp NJ, Cerhan JR, Spinelli JJ, Wang SS, Nieters A, Vijai J, Yeager M, Wang Z, Ghesquières H, McKay J, ... ... Wu X, et al. Genetically predicted longer telomere length is associated with increased risk of B-cell lymphoma subtypes. Human Molecular Genetics. 25: 1663-76. PMID 27008888 DOI: 10.1093/Hmg/Ddw027 |
0.401 |
|
| 2016 |
Li R, Pu X, Chang JY, Ye Y, Komaki R, Minna JD, Roth JA, Han B, Wu X. MiRNA-Related Genetic Variations Associated with Radiotherapy-Induced Toxicities in Patients with Locally Advanced Non-Small Cell Lung Cancer. Plos One. 11: e0150467. PMID 26991123 DOI: 10.1371/Journal.Pone.0150467 |
0.481 |
|
| 2016 |
Kang X, Liu H, Onaitis MW, Liu Z, Owzar K, Han Y, Su L, Wei Y, Hung RJ, Brhane Y, McLaughlin J, Brennan P, Bickeböller H, Rosenberger A, Houlston RS, ... ... Wu X, et al. Polymorphisms of the centrosomal gene (FGFR1OP) and lung cancer risk: a meta-analysis of 14 463 cases and 44 188 controls. Carcinogenesis. PMID 26905588 DOI: 10.1093/Carcin/Bgw014 |
0.521 |
|
| 2016 |
Zhao L, Pu X, Ye Y, Lu C, Chang JY, Wu X. Association between Genetic Variants in DNA Double-Strand Break Repair Pathways and Risk of Radiation Therapy-Induced Pneumonitis and Esophagitis in Non-Small Cell Lung Cancer. Cancers. 8. PMID 26901225 DOI: 10.3390/Cancers8020023 |
0.485 |
|
| 2016 |
Hildebrandt MA, Reyes ME, Lin M, He Y, Nguyen SV, Hawk ET, Wu X. Germline genetic variants in the Wnt/beta-catenin pathway as predictors of colorectal cancer risk. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 26809274 DOI: 10.1158/1055-9965.Epi-15-0834 |
0.383 |
|
| 2016 |
Figueroa JD, Middlebrooks CD, Banday AR, Ye Y, Garcia-Closas M, Chatterjee N, Koutros S, Kiemeney LA, Rafnar T, Bishop T, Barnes HF, Matullo G, Golka K, Gago-Dominguez M, Taylor J, ... ... Wu X, et al. Identification of a novel susceptibility locus at 13q34 and refinement of the 20p12.2 region as a multi-signal locus associated with bladder cancer risk in individuals of European ancestry. Human Molecular Genetics. PMID 26732427 DOI: 10.1093/Hmg/Ddv492 |
0.457 |
|
| 2016 |
Lin EH, Kim EY, Wang L, Fong C, Shankaran V, Wu X, Wood DE, Yeung RS, Tian Q. ADAPT therapy vs capecitabine bevacizumab in stage IV colorectal cancer: Pooled 10-year survival experience and a phase II study update. Journal of Clinical Oncology. 34: e15046-e15046. DOI: 10.1200/Jco.2016.34.15_Suppl.E15046 |
0.396 |
|
| 2016 |
Takahashi K, Wang F, Kantarjian HM, Denaha D, Khann K, Patel KP, Neelapu SS, Gumbs C, Bueso-Ramos CE, DiNardo CD, Colla S, Ravandi F, Zhang J, Wu X, Samaniego F, et al. Clonal Hematopoiesis Increases Risk of Therapy-Related Myeloid Neoplasms Blood. 128: 38-38. DOI: 10.1182/Blood.V128.22.38.38 |
0.329 |
|
| 2016 |
Lin J, Zhang L, Ye Y, Oba T, Gentile E, Wang J, Zhao Y, Gu J, Wistuba I, Roth JA, Wu X, Ji L. Abstract 964: Circulating biomarker miRNA-150 promotes tumor cell proliferation and progression by targeting SRC kinase signaling inhibitor 1 (SRCIN1) in non-small cell lung cancer Cancer Research. 76: 964-964. DOI: 10.1158/1538-7445.Am2016-964 |
0.334 |
|
| 2016 |
Kachuri L, Smith GD, Liu G, Landi MT, Christiani DC, Caporaso NE, McKay JD, Wu X, Aldrich MC, Rennert G, Teare D, Chen C, Goodman GE, Doherty JA, Field JK, et al. Abstract 817: Mendelian randomization and mediation analysis of 5p15.33, telomere length and lung cancer risk Cancer Research. 76: 817-817. DOI: 10.1158/1538-7445.Am2016-817 |
0.518 |
|
| 2016 |
Pierzynski JA, Ye Y, Rodriguez A, Hildebrandt MAT, Kamat AM, Dinney CPN, Wu X. Abstract 816: Genetic variants in the dopaminergic system and bladder cancer clinical outcomes Cancer Research. 76: 816-816. DOI: 10.1158/1538-7445.Am2016-816 |
0.53 |
|
| 2016 |
Zhang L, Ye Y, Tu H, Hildebrandt MAt, Heymach JV, Roth JA, Gu J, Wu X. Abstract 809: Dietary iron intake, genetic variants in microRNA related iron regulatory pathway genes, and the risk of non-small cell lung cancer Cancer Research. 76: 809-809. DOI: 10.1158/1538-7445.Am2016-809 |
0.45 |
|
| 2016 |
Sanchez-Espiridion B, White L, Mishra L, Raju GS, Kopetz S, Gu J, Ye Y, Wu X, Liang D. Abstract 8: Global and targeted metabolomic profiling of colorectal cancer progression Cancer Research. 76: 8-8. DOI: 10.1158/1538-7445.Am2016-8 |
0.412 |
|
| 2016 |
Takahashi K, Wang F, Kantarjian H, Denaha D, Thompson E, Gumbs C, Patel K, Neelapu S, Wang Y, Bohannan Z, DiNardo C, Ravandi F, Estrov Z, Colla S, Zhang J, ... Wu X, et al. Abstract 5033: Clonal origin of therapy-related myeloid neoplasms Cancer Research. 76: 5033-5033. DOI: 10.1158/1538-7445.Am2016-5033 |
0.354 |
|
| 2016 |
Carreras-Torres R, Johansson M, Scelo G, Haycock P, Purdue M, Wu X, Houlston R, Chanock S, Brennan P. Abstract 4349: Identifying causal risk factors of metabolic syndrome for renal cell carcinoma. A Mendelian randomization approach Cancer Research. 76: 4349-4349. DOI: 10.1158/1538-7445.Am2016-4349 |
0.435 |
|
| 2016 |
Reyes ME, Zhou Y, Ye Y, Wu X, Hildebrandt M. Abstract 3466: Mental health-related quality of life assessment at diagnosis as a predictor for prognosis of colorectal cancer patients Cancer Research. 76: 3466-3466. DOI: 10.1158/1538-7445.Am2016-3466 |
0.352 |
|
| 2016 |
Tu H, Heymach JV, Weng C, Ye Y, Pierzynski JA, Roth JA, Wu X. Abstract 1749: Different dietary patterns and reduction of lung cancer risk: a large case-control study in the U.S Cancer Research. 76: 1749-1749. DOI: 10.1158/1538-7445.Am2016-1749 |
0.501 |
|
| 2016 |
Shu X, Hildebrandt MA, Reis RBd, Ye Y, Gu J, Wood CG, Wu X. Abstract 1527: Urinary miRNAs as predictors of tumor metastasis in localized patients with clear cell renal cell carcinoma: a pilot study Cancer Research. 76: 1527-1527. DOI: 10.1158/1538-7445.Am2016-1527 |
0.341 |
|
| 2016 |
Lin S, Raju GS, Huff C, Gu J, Chen J, Kopetz S, Menter DG, Hawk E, Mishra L, Ye Y, Wu X. Abstract 143: Mutational landscape of colorectal adenomas reveals potential signatures for progression Cancer Research. 76: 143-143. DOI: 10.1158/1538-7445.Am2016-143 |
0.369 |
|
| 2016 |
Oba T, Ye Y, Zhang L, Lin J, Gentile E, Wang J, Zhao Y, Gu J, Wistuba I, Roth JA, Wu X, Ji L. Abstract 1115: Serum miR152 as a novel prognostic biomarker and potential tumor suppressor for early stage non-small cell lung cancer Cancer Research. 76: 1115-1115. DOI: 10.1158/1538-7445.Am2016-1115 |
0.353 |
|
| 2016 |
Williams S, Kamat A, Mmeje C, Morales E, Ye Y, Huang M, Wang D, Dinney C, Wu X. Mp83-06 Variants In The Inflammatory Gene Pathway Are Predictive Of Recurrence And Progression In Patients Who Received Bacillus Of Calmette And Guérin (Bcg) For Non-Muscle Invasive Bladder Cancer The Journal of Urology. 195. DOI: 10.1016/J.Juro.2016.02.2188 |
0.377 |
|
| 2015 |
Jim HS, Lin HY, Tyrer JP, Lawrenson K, Dennis J, Chornokur G, Chen Z, Chen AY, Permuth-Wey J, Aben KK, Anton-Culver H, Antonenkova N, Bruinsma F, Bandera EV, Bean YT, ... ... Wu X, et al. Common Genetic Variation in Circadian Rhythm Genes and Risk of Epithelial Ovarian Cancer (EOC). Journal of Genetics and Genome Research. 2. PMID 26807442 |
0.404 |
|
| 2015 |
Wu X, Hildebrandt MA, Ye Y, Chow WH, Gu J, Cunningham S, Zhao H, Hawk ET, Wagar E, Rodriguez A, Hamilton SR. Cohort Profile: The MD Anderson Cancer Patients and Survivors Cohort (MDA-CPSC). International Journal of Epidemiology. PMID 26686840 DOI: 10.1093/ije/dyv317 |
0.311 |
|
| 2015 |
Daniel CR, Shu X, Ye Y, Gu J, Raju GS, Kopetz S, Wu X. Severe obesity prior to diagnosis limits survival in colorectal cancer patients evaluated at a large cancer centre. British Journal of Cancer. PMID 26679375 DOI: 10.1038/Bjc.2015.424 |
0.349 |
|
| 2015 |
Tu H, Gu J, Meng QH, Kim J, Davis JW, He Y, Wagar EA, Thompson TC, Logothetis CJ, Wu X. Mitochondrial DNA copy number in peripheral blood leukocytes and the aggressiveness of localized prostate cancer. Oncotarget. PMID 26515605 DOI: 10.18632/Oncotarget.5889 |
0.423 |
|
| 2015 |
Sampson JN, Wheeler WA, Yeager M, Panagiotou O, Wang Z, Berndt SI, Lan Q, Abnet CC, Amundadottir LT, Figueroa JD, Landi MT, Mirabello L, Savage SA, Taylor PR, Vivo ID, ... Wu X, et al. Analysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for Thirteen Cancer Types. Journal of the National Cancer Institute. 107. PMID 26464424 DOI: 10.1093/Jnci/Djv279 |
0.454 |
|
| 2015 |
Lawrenson K, Iversen ES, Tyrer J, Weber RP, Concannon P, Hazelett DJ, Li Q, Marks JR, Berchuck A, Lee JM, Aben KK, Anton-Culver H, Antonenkova N, ... ... Wu X, et al. Common Variants at the CHEK2 Gene Locus and Risk of Epithelial Ovarian Cancer. Carcinogenesis. PMID 26424751 DOI: 10.1093/carcin/bgv138 |
0.379 |
|
| 2015 |
Amankwah EK, Lin HY, Tyrer JP, Lawrenson K, Dennis J, Chornokur G, Aben KK, Anton-Culver H, Antonenkova N, Bruinsma F, Bandera EV, Bean YT, Beckmann MW, Bisogna M, Bjorge L, ... ... Wu X, et al. Epithelial-Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk. Genetic Epidemiology. PMID 26399219 DOI: 10.1002/Gepi.21921 |
0.474 |
|
| 2015 |
Lawrenson K, Li Q, Kar S, Seo JH, Tyrer J, Spindler TJ, Lee J, Chen Y, Karst A, Drapkin R, Aben KK, Anton-Culver H, Antonenkova N, Baker H, ... ... Wu X, et al. Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer. Nature Communications. 6: 8234. PMID 26391404 DOI: 10.1038/Ncomms9234 |
0.484 |
|
| 2015 |
Sun Y, Zhang L, Zhao L, Wu X, Gu J. Association of leukocyte telomere length in peripheral blood leukocytes with endometrial cancer risk in Caucasian Americans. Carcinogenesis. PMID 26385889 DOI: 10.1093/Carcin/Bgv133 |
0.508 |
|
| 2015 |
Brenner DR, Amos CI, Brhane Y, Timofeeva MN, Caporaso N, Wang Y, Christiani DC, Bickeböller H, Yang P, Albanes D, Stevens VL, Gapstur S, McKay J, Boffetta P, Zaridze D, ... ... Wu X, et al. Identification of lung cancer histology-specific variants applying Bayesian framework variant prioritization approaches within the TRICL and ILCCO consortia. Carcinogenesis. PMID 26363033 DOI: 10.1093/Carcin/Bgv128 |
0.453 |
|
| 2015 |
Sun Y, Zhang L, Ho SS, Wu X, Gu J. Lower mitochondrial DNA copy number in peripheral blood leukocytes increases the risk of endometrial cancer. Molecular Carcinogenesis. PMID 26258624 DOI: 10.1002/Mc.22373 |
0.474 |
|
| 2015 |
Lu Y, Cuellar G, Painter JN, Nyholt D, Morris AP, Fasching PA, Hein A, Burghaus S, Beckmann MW, Lambrechts D, Van Nieuwenhuysen E, Vergote I, Vanderstichele A, ... ... Wu X, et al. Shared genetics underlying epidemiological association between endometriosis and ovarian cancer. Human Molecular Genetics. PMID 26231222 DOI: 10.1093/Hmg/Ddv306 |
0.467 |
|
| 2015 |
Kar SP, Tyrer JP, Li Q, Lawrenson K, Aben KK, Anton-Culver H, Antonenkova N, Chenevix-Trench G, Baker H, Bandera E, Bean YT, Beckmann MW, Berchuck A, Bisogna M, Bjørge L, ... ... Wu X, et al. Network-based integration of GWAS and gene expression identifies a HOX-centric network associated with serous ovarian cancer risk. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 26209509 DOI: 10.1158/1055-9965.Epi-14-1270 |
0.443 |
|
| 2015 |
Pierzynski JA, Hildebrandt MA, Kamat AM, Lin J, Ye Y, Dinney CP, Wu X. Genetic Variants within the Wnt/β-Catenin Signaling Pathway as Indicators of Bladder Cancer Risk. The Journal of Urology. PMID 26173102 DOI: 10.1016/J.Juro.2015.07.032 |
0.42 |
|
| 2015 |
Hildebrandt MA, Roth JA, Vaporciyan AA, Pu X, Ye Y, Correa AM, Kim JY, Swisher SG, Wu X. Genetic variation in the TNF/TRAF2/ASK1/p38 kinase signaling pathway as markers for postoperative pulmonary complications in lung cancer patients. Scientific Reports. 5: 12068. PMID 26165383 DOI: 10.1038/Srep12068 |
0.47 |
|
| 2015 |
Chornokur G, Lin HY, Tyrer JP, Lawrenson K, Dennis J, Amankwah EK, Qu X, Tsai YY, Jim HS, Chen Z, Chen AY, Permuth-Wey J, Aben KKh, Anton-Culver H, Antonenkova N, ... ... Wu X, et al. Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk. Plos One. 10: e0128106. PMID 26091520 DOI: 10.1371/Journal.Pone.0128106 |
0.491 |
|
| 2015 |
Hollestelle A, van der Baan FH, Berchuck A, Johnatty SE, Aben KK, Agnarsson BA, Aittomäki K, Alducci E, Andrulis IL, Anton-Culver H, Antonenkova NN, Antoniou AC, Apicella C, Arndt V, ... ... Wu X, et al. No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. Gynecologic Oncology. PMID 25940428 DOI: 10.1016/J.Ygyno.2015.04.034 |
0.45 |
|
| 2015 |
Williams SB, Ye Y, Huang M, Chang DW, Kamat AM, Pu X, Dinney CP, Wu X. Mitochondrial DNA Content as Risk Factor for Bladder Cancer and Its Association with Mitochondrial DNA Polymorphisms. Cancer Prevention Research (Philadelphia, Pa.). 8: 607-13. PMID 25896234 DOI: 10.1158/1940-6207.Capr-14-0414 |
0.509 |
|
| 2015 |
Chen LS, Hung RJ, Baker T, Horton A, Culverhouse R, Saccone N, Cheng I, Deng B, Han Y, Hansen HM, Horsman J, Kim C, Lutz S, Rosenberger A, Aben KK, ... ... Wu X, et al. CHRNA5 risk variant predicts delayed smoking cessation and earlier lung cancer diagnosis--a meta-analysis. Journal of the National Cancer Institute. 107. PMID 25873736 DOI: 10.1093/Jnci/Djv100 |
0.329 |
|
| 2015 |
Wang Y, Ye Y, Lin J, Meyer L, Wu X, Lu K, Liang D. Genetic variants in matrix metalloproteinase genes as disposition factors for ovarian cancer risk, survival, and clinical outcome. Molecular Carcinogenesis. 54: 430-9. PMID 25867973 DOI: 10.1002/Mc.22111 |
0.526 |
|
| 2015 |
Ke HL, Lin J, Ye Y, Wu WJ, Lin HH, Wei H, Huang M, Chang DW, Dinney CP, Wu X. Genetic Variations in Glutathione Pathway Genes Predict Cancer Recurrence in Patients Treated with Transurethral Resection and Bacillus Calmette-Guerin Instillation for Non-muscle Invasive Bladder Cancer. Annals of Surgical Oncology. PMID 25851338 DOI: 10.1016/J.Urols.2015.06.030 |
0.428 |
|
| 2015 |
Shu X, Purdue MP, Ye Y, Wood CG, Chen M, Wang Z, Albanes D, Pu X, Huang M, Stevens VL, Diver WR, Gapstur SM, Virtamo J, Chow WH, Tannir NM, ... Wu X, et al. Multilevel-analysis identify a cis-expression quantitative trait locus associated with risk of renal cell carcinoma. Oncotarget. 6: 4097-109. PMID 25784652 DOI: 10.18632/Oncotarget.3001 |
0.309 |
|
| 2015 |
Machiela MJ, Zhou W, Sampson JN, Dean MC, Jacobs KB, Black A, Brinton LA, Chang IS, Chen C, Chen C, Chen K, Cook LS, Crous Bou M, De Vivo I, Doherty J, ... ... Wu X, et al. Characterization of large structural genetic mosaicism in human autosomes. American Journal of Human Genetics. 96: 487-97. PMID 25748358 DOI: 10.1016/J.Ajhg.2015.01.011 |
0.32 |
|
| 2015 |
Sun W, Wen CP, Lin J, Wen C, Pu X, Huang M, Tsai MK, Tsao CK, Wu X, Chow WH. ABO blood types and cancer risk--a cohort study of 339,432 subjects in Taiwan. Cancer Epidemiology. 39: 150-6. PMID 25600007 DOI: 10.1016/J.Canep.2014.12.006 |
0.451 |
|
| 2015 |
Kuchenbaecker KB, Ramus SJ, Tyrer J, Lee A, Shen HC, Beesley J, Lawrenson K, McGuffog L, Healey S, Lee JM, Spindler TJ, Lin YG, Pejovic T, Bean Y, Li Q, ... ... Wu X, et al. Identification of six new susceptibility loci for invasive epithelial ovarian cancer. Nature Genetics. 47: 164-71. PMID 25581431 DOI: 10.1038/ng.3185 |
0.354 |
|
| 2015 |
Vijai J, Wang Z, Berndt SI, Skibola CF, Slager SL, de Sanjose S, Melbye M, Glimelius B, Bracci PM, Conde L, Birmann BM, Wang SS, Brooks-Wilson AR, Lan Q, de Bakker PI, ... ... Wu X, et al. A genome-wide association study of marginal zone lymphoma shows association to the HLA region. Nature Communications. 6: 5751. PMID 25569183 DOI: 10.1038/Ncomms6751 |
0.381 |
|
| 2015 |
Lee AW, Tyrer JP, Doherty JA, Stram DA, Kupryjanczyk J, Dansonka-Mieszkowska A, Plisiecka-Halasa J, Spiewankiewicz B, Myers EJ, Chenevix-Trench G, Fasching PA, Beckmann MW, Ekici AB, ... ... Wu X, et al. Evaluating the ovarian cancer gonadotropin hypothesis: a candidate gene study. Gynecologic Oncology. 136: 542-8. PMID 25528498 DOI: 10.1016/J.Ygyno.2014.12.017 |
0.418 |
|
| 2015 |
Melkonian SC, Wang X, Gu J, Matin SF, Tannir NM, Wood CG, Wu X. Mitochondrial DNA copy number in peripheral blood leukocytes and the risk of clear cell renal cell carcinoma. Carcinogenesis. 36: 249-55. PMID 25524925 DOI: 10.1093/Carcin/Bgu248 |
0.399 |
|
| 2015 |
Liu X, Meng QH, Ye Y, Hildebrandt MA, Gu J, Wu X. Prognostic significance of pretreatment serum levels of albumin, LDH and total bilirubin in patients with non-metastatic breast cancer. Carcinogenesis. 36: 243-8. PMID 25524924 DOI: 10.1093/Carcin/Bgu247 |
0.412 |
|
| 2015 |
Lin J, Blalock JA, Chen M, Ye Y, Gu J, Cohen L, Cinciripini PM, Wu X. Depressive symptoms and short telomere length are associated with increased mortality in bladder cancer patients. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 24: 336-43. PMID 25416716 DOI: 10.1158/1055-9965.Epi-14-0992 |
0.362 |
|
| 2015 |
Wassenaar CA, Ye Y, Cai Q, Aldrich MC, Knight J, Spitz MR, Wu X, Blot WJ, Tyndale RF. CYP2A6 reduced activity gene variants confer reduction in lung cancer risk in African American smokers--findings from two independent populations. Carcinogenesis. 36: 99-103. PMID 25416559 DOI: 10.1093/Carcin/Bgu235 |
0.515 |
|
| 2015 |
Pardini B, Rosa F, Naccarati A, Vymetalkova V, Ye Y, Wu X, di Gaetano C, Buchler T, Novotny J, Matullo G, Vodicka P. Polymorphisms in microRNA genes as predictors of clinical outcomes in colorectal cancer patients. Carcinogenesis. 36: 82-6. PMID 25368035 DOI: 10.1093/Carcin/Bgu224 |
0.451 |
|
| 2015 |
Wen CP, Zhang F, Liang D, Wen C, Gu J, Skinner H, Chow WH, Ye Y, Pu X, Hildebrandt MA, Huang M, Chen CH, Hsiung CA, Tsai MK, Tsao CK, ... Wu X, et al. The ability of bilirubin in identifying smokers with higher risk of lung cancer: a large cohort study in conjunction with global metabolomic profiling. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 21: 193-200. PMID 25336700 DOI: 10.1158/1078-0432.CCR-14-0748 |
0.355 |
|
| 2015 |
Kim ES, Ye Y, Vaporciyan AA, Xing J, Huang M, Gu J, Roth JA, Lippman SM, Wu X. Telomere length and recurrence risk after curative resection in patients with early-stage non-small-cell lung cancer: a prospective cohort study. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 10: 302-8. PMID 25299235 DOI: 10.1097/Jto.0000000000000398 |
0.444 |
|
| 2015 |
Liang S, Sanchez-Espiridion B, Xie H, Ma J, Wu X, Liang D. Determination of proline in human serum by a robust LC-MS/MS method: application to identification of human metabolites as candidate biomarkers for esophageal cancer early detection and risk stratification. Biomedical Chromatography : Bmc. 29: 570-7. PMID 25164985 DOI: 10.1002/Bmc.3315 |
0.303 |
|
| 2015 |
Tan W, Gu J, Huang M, Wu X, Hildebrandt MA. Epigenetic analysis of microRNA genes in tumors from surgically resected lung cancer patients and association with survival. Molecular Carcinogenesis. 54: E45-51. PMID 24665010 DOI: 10.1002/Mc.22149 |
0.344 |
|
| 2015 |
Xie H, Gong Y, Dai J, Wu X, Gu J. Genetic variations in base excision repair pathway and risk of bladder cancer: a case-control study in the United States. Molecular Carcinogenesis. 54: 50-7. PMID 24038406 DOI: 10.1002/mc.22073 |
0.444 |
|
| 2015 |
Tu H, Pu X, Daniel-MacDougall C, Melkonian SC, Ye Y, Raju GS, Kopetz S, Wu X. Abstract 869: Body mass index, weight gain, and physical activity during adulthood in relation to colorectal cancer risk Cancer Research. 75: 869-869. DOI: 10.1158/1538-7445.Am2015-869 |
0.412 |
|
| 2015 |
Melkonian SC, Daniel CR, Ye Y, Tannir NM, Karam JA, Matin SF, Wood CG, Wu X. Abstract 836: Gene-environment interaction of genome-wide association study-identified susceptibility loci and meat-cooking mutagens in renal cell carcinoma etiology Cancer Research. 75: 836-836. DOI: 10.1158/1538-7445.Am2015-836 |
0.447 |
|
| 2015 |
Menon VK, Gottumukkala RS, Chen J, Su X, Mistry N, Majumdar A, Shin J, Li S, Shetty K, Wu X, Weston B, Miller E, Stroehlein JR, Davila ML, Shafi MA, et al. Abstract 67: Genomic and mutational profiling of human colon adenomas reveals early driver mutations and a TGF-β-CEA regulated profile Cancer Research. 75: 67-67. DOI: 10.1158/1538-7445.Am2015-67 |
0.325 |
|
| 2015 |
Pu X, Ajani JA, Gu J, Gu X, Ye Y, Wu X. Abstract 5587: Personalized risk prediction tool for esophageal adenocarcinoma in Caucasian population Cancer Research. 75: 5587-5587. DOI: 10.1158/1538-7445.Am2015-5587 |
0.438 |
|
| 2015 |
Zhang L, Roth JA, Lian J, Ye Y, Gu J, Wu X. Abstract 4594: Serum microRNA signatures predict recurrence and survival in Caucasian patients with early stage non-small cell lung cancer Cancer Research. 75: 4594-4594. DOI: 10.1158/1538-7445.Am2015-4594 |
0.395 |
|
| 2015 |
Chen J, Chen J, Zhang J, Phan L, Muñoz NM, Katz LH, Gi Y, Menon VK, Shin J, Jeong YS, Jogunoori W, Farci P, Shetty K, Su X, Pandita TK, ... ... Wu X, et al. Abstract 3900: Genomic landscape of human cancer reveals dysregulated TGF-β signaling with prognostic significance Cancer Research. 75: 3900-3900. DOI: 10.1158/1538-7445.Am2015-3900 |
0.352 |
|
| 2015 |
Daniel CR, Shu X, Ye Y, Gu J, Raju GS, Kopetz S, Wu X. Abstract 3737: Severe obesity and colorectal cancer patient survival Cancer Research. 75: 3737-3737. DOI: 10.1158/1538-7445.Am2015-3737 |
0.383 |
|
| 2015 |
Pierzynski JA, Hildebrandt MA, Ye Y, Roth JA, Wu X. Abstract 3707: Baseline quality of life and genetic determinants and the impact on five-year lung cancer survival Cancer Research. 75: 3707-3707. DOI: 10.1158/1538-7445.Am2015-3707 |
0.436 |
|
| 2015 |
Santibanez M, Rodriguez A, Hildebrandt MA, Chang DW, Wu X. Abstract 3056: Mitochondrial DNA copy number and risk of second primary tumors in long-term breast cancer survivors Cancer Research. 75: 3056-3056. DOI: 10.1158/1538-7445.Am2015-3056 |
0.367 |
|
| 2015 |
Perez JM, Gu J, Tannir NM, Matin S, Karam JA, Chang DW, Herrera LA, Wood CG, Wu X. Abstract 2953: Genomic DNA hypomethylation as an independent risk factor for renal cell carcinoma Cancer Research. 75: 2953-2953. DOI: 10.1158/1538-7445.Am2015-2953 |
0.458 |
|
| 2015 |
Lin J, Zandi R, Gu J, Ye Y, Pertsemlidis A, Wu X, Roth JA, Ji L. Abstract 196: A SNP in the 3′-untranslated region of FZD4 linked to lung cancer survival modulates a miRNA-mediated FZD4 transcript binding, cleavage, expression, and Wnt-signaling in NSCLC cells Cancer Research. 75: 196-196. DOI: 10.1158/1538-7445.Am2015-196 |
0.373 |
|
| 2015 |
Sanchez-Espirdion B, Tannir NM, Matin SF, Karam JA, Huang M, Wood CG, Wu X, Gu J. Abstract 1827: Detection of recurrent renal cell carcinoma biomarkers by metabolite ratios Cancer Research. 75: 1827-1827. DOI: 10.1158/1538-7445.Am2015-1827 |
0.369 |
|
| 2015 |
Williams S, Ye Y, Huang M, Cheng D, Kamat A, Pu X, Dinney C, Wu X. Mp36-01 Mitochondrial Dna Content As Risk Factor For Bladder Cancer And Its Association With Mitochondrial Dna Polymorphisms The Journal of Urology. 193. DOI: 10.1016/J.Juro.2015.02.729 |
0.359 |
|
| 2014 |
Fu YP, Kohaar I, Moore LE, Lenz P, Figueroa JD, Tang W, Porter-Gill P, Chatterjee N, Scott-Johnson A, Garcia-Closas M, Muchmore B, Baris D, Paquin A, Ylaya K, Schwenn M, ... ... Wu X, et al. The 19q12 bladder cancer GWAS signal: association with cyclin E function and aggressive disease. Cancer Research. 74: 5808-18. PMID 25320178 DOI: 10.1158/0008-5472.Can-14-1531 |
0.429 |
|
| 2014 |
Zhang J, Fujimoto J, Zhang J, Wedge DC, Song X, Zhang J, Seth S, Chow CW, Cao Y, Gumbs C, Gold KA, Kalhor N, Little L, Mahadeshwar H, Moran C, ... ... Wu X, et al. Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing. Science (New York, N.Y.). 346: 256-9. PMID 25301631 DOI: 10.1126/Science.1256930 |
0.387 |
|
| 2014 |
Skibola CF, Berndt SI, Vijai J, Conde L, Wang Z, Yeager M, de Bakker PI, Birmann BM, Vajdic CM, Foo JN, Bracci PM, Vermeulen RC, Slager SL, de Sanjose S, Wang SS, ... ... Wu X, et al. Genome-wide association study identifies five susceptibility loci for follicular lymphoma outside the HLA region. American Journal of Human Genetics. 95: 462-71. PMID 25279986 DOI: 10.1016/J.Ajhg.2014.09.004 |
0.385 |
|
| 2014 |
He Y, Gu J, Strom S, Logothetis CJ, Kim J, Wu X. The prostate cancer susceptibility variant rs2735839 near KLK3 gene is associated with aggressive prostate cancer and can stratify gleason score 7 patients. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 5133-9. PMID 25274378 DOI: 10.1158/1078-0432.Ccr-14-0661 |
0.419 |
|
| 2014 |
Baruah A, Buttar N, Chandra R, Chen X, Clemons NJ, Compare D, El-Rifai W, Gu J, Houchen CW, Koh SY, Li W, Nardone G, Phillips WA, Sharma A, Singh I, ... ... Wu X, et al. Translational research on Barrett's esophagus. Annals of the New York Academy of Sciences. 1325: 170-86. PMID 25266024 DOI: 10.1111/Nyas.12531 |
0.348 |
|
| 2014 |
Wen CP, Lee JH, Tai YP, Wen C, Wu SB, Tsai MK, Hsieh DP, Chiang HC, Hsiung CA, Hsu CY, Wu X. High serum iron is associated with increased cancer risk. Cancer Research. 74: 6589-97. PMID 25228650 DOI: 10.1158/0008-5472.Can-14-0360 |
0.444 |
|
| 2014 |
Kelemen LE, Terry KL, Goodman MT, Webb PM, Bandera EV, McGuire V, Rossing MA, Wang Q, Dicks E, Tyrer JP, Song H, Kupryjanczyk J, Dansonka-Mieszkowska A, Plisiecka-Halasa J, Timorek A, ... ... Wu X, et al. Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk. Molecular Nutrition & Food Research. 58: 2023-35. PMID 25066213 DOI: 10.1002/Mnfr.201400068 |
0.337 |
|
| 2014 |
Pu X, Wang L, Chang JY, Hildebrandt MA, Ye Y, Lu C, Skinner HD, Niu N, Jenkins GD, Komaki R, Minna JD, Roth JA, Weinshilboum RM, Wu X. Inflammation-related genetic variants predict toxicity following definitive radiotherapy for lung cancer. Clinical Pharmacology and Therapeutics. 96: 609-15. PMID 25054431 DOI: 10.1038/Clpt.2014.154 |
0.479 |
|
| 2014 |
Wang Z, Zhu B, Zhang M, Parikh H, Jia J, Chung CC, Sampson JN, Hoskins JW, Hutchinson A, Burdette L, Ibrahim A, Hautman C, Raj PS, Abnet CC, Adjei AA, ... Wu X, et al. Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33. Human Molecular Genetics. 23: 6616-33. PMID 25027329 DOI: 10.1093/Hmg/Ddu363 |
0.36 |
|
| 2014 |
Stewart DJ, Chang DW, Ye Y, Spitz M, Lu C, Shu X, Wampfler JA, Marks RS, Garces YI, Yang P, Wu X. Wnt signaling pathway pharmacogenetics in non-small cell lung cancer. The Pharmacogenomics Journal. 14: 509-22. PMID 24980784 DOI: 10.1038/Tpj.2014.21 |
0.441 |
|
| 2014 |
Sun Y, Gu J, Ajani JA, Chang DW, Wu X, Stroehlein JR. Genetic and intermediate phenotypic susceptibility markers of gastric cancer in Hispanic Americans: a case-control study. Cancer. 120: 3040-8. PMID 24962126 DOI: 10.1002/Cncr.28792 |
0.453 |
|
| 2014 |
Wang Y, McKay JD, Rafnar T, Wang Z, Timofeeva MN, Broderick P, Zong X, Laplana M, Wei Y, Han Y, Lloyd A, Delahaye-Sourdeix M, Chubb D, Gaborieau V, Wheeler W, ... ... Wu X, et al. Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer. Nature Genetics. 46: 736-41. PMID 24880342 DOI: 10.1038/Ng.3002 |
0.498 |
|
| 2014 |
Saxena R, Bjonnes A, Prescott J, Dib P, Natt P, Lane J, Lerner M, Cooper JA, Ye Y, Li KW, Maubaret CG, Codd V, Brackett D, Mirabello L, Kraft P, ... ... Wu X, et al. Genome-wide association study identifies variants in casein kinase II (CSNK2A2) to be associated with leukocyte telomere length in a Punjabi Sikh diabetic cohort. Circulation. Cardiovascular Genetics. 7: 287-95. PMID 24795349 DOI: 10.1161/Circgenetics.113.000412 |
0.331 |
|
| 2014 |
Pu X, Hildebrandt MA, Lu C, Roth JA, Stewart DJ, Zhao Y, Heist RS, Ye Y, Chang DW, Su L, Minna JD, Lippman SM, Spitz MR, Christiani DC, Wu X. Inflammation-related genetic variations and survival in patients with advanced non-small cell lung cancer receiving first-line chemotherapy. Clinical Pharmacology and Therapeutics. 96: 360-9. PMID 24755914 DOI: 10.1038/Clpt.2014.89 |
0.466 |
|
| 2014 |
He Y, Gong Y, Gu J, Lee JJ, Lippman SM, Wu X. Increased leukocyte mitochondrial DNA copy number is associated with oral premalignant lesions: an epidemiology study. Carcinogenesis. 35: 1760-4. PMID 24743515 DOI: 10.1093/Carcin/Bgu093 |
0.398 |
|
| 2014 |
Sanchez-Espiridion B, Chen M, Chang JY, Lu C, Chang DW, Roth JA, Wu X, Gu J. Telomere length in peripheral blood leukocytes and lung cancer risk: a large case-control study in Caucasians. Cancer Research. 74: 2476-86. PMID 24618342 DOI: 10.1158/0008-5472.Can-13-2968 |
0.476 |
|
| 2014 |
Coscio A, Chang DW, Roth JA, Ye Y, Gu J, Yang P, Wu X. Genetic variants of the Wnt signaling pathway as predictors of recurrence and survival in early-stage non-small cell lung cancer patients. Carcinogenesis. 35: 1284-91. PMID 24517998 DOI: 10.1093/Carcin/Bgu034 |
0.437 |
|
| 2014 |
Purdue MP, Ye Y, Wang Z, Colt JS, Schwartz KL, Davis FG, Rothman N, Chow WH, Wu X, Chanock SJ. A genome-wide association study of renal cell carcinoma among African Americans. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 23: 209-14. PMID 24220910 DOI: 10.1158/1055-9965.Epi-13-0818 |
0.409 |
|
| 2014 |
Earp MA, Kelemen LE, Magliocco AM, Swenerton KD, Chenevix-Trench G, Lu Y, Hein A, Ekici AB, Beckmann MW, Fasching PA, Lambrechts D, Despierre E, Vergote I, ... ... Wu X, et al. Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA. Human Genetics. 133: 481-97. PMID 24190013 DOI: 10.1007/S00439-013-1383-3 |
0.495 |
|
| 2014 |
Figueroa JD, Ye Y, Siddiq A, Garcia-Closas M, Chatterjee N, Prokunina-Olsson L, Cortessis VK, Kooperberg C, Cussenot O, Benhamou S, Prescott J, Porru S, Dinney CP, Malats N, Baris D, ... ... Wu X, et al. Genome-wide association study identifies multiple loci associated with bladder cancer risk. Human Molecular Genetics. 23: 1387-98. PMID 24163127 DOI: 10.1093/Hmg/Ddt519 |
0.494 |
|
| 2014 |
Meng QH, Xu E, Hildebrandt MA, Liang D, Lu K, Ye Y, Wagar EA, Wu X. Genetic variants in the fibroblast growth factor pathway as potential markers of ovarian cancer risk, therapeutic response, and clinical outcome. Clinical Chemistry. 60: 222-32. PMID 24146310 DOI: 10.1373/Clinchem.2013.211490 |
0.465 |
|
| 2014 |
Rodriguez MA, Sanchez-Espiridion B, Gu J, Wu X, Zandstra FA, Palos GR. Leukocyte telomere length and risk of secondary primary tumors in long-term breast cancer survivors. Journal of Clinical Oncology. 32: 9599-9599. DOI: 10.1200/Jco.2014.32.15_Suppl.9599 |
0.35 |
|
| 2014 |
Zhang J, Fujimoto J, Zhang J, Cao Y, Chow C, Gold KA, Gumbs C, Heymach J, Kalhor N, Moran C, Protopopov A, Seth S, Song X, Swisher S, Tang J, ... ... Wu X, et al. Intratumor heterogeneity (ITH) of lung adenocarcinomas defined by multiregion whole exome sequencing (WES). Journal of Clinical Oncology. 32: 11032-11032. DOI: 10.1200/Jco.2014.32.15_Suppl.11032 |
0.336 |
|
| 2014 |
Wu X, Wen CP, Ye Y, Tsai M, Pu X, Chow W, Huff C, Cunningham S, Huang M, Wu SB, Tsao CK, Gu J. Abstract LB-298: The use of lung cancer risk prediction model to stratify heavy smokers: The power of routinely collected lab data Cancer Research. 74. DOI: 10.1158/1538-7445.Am2014-Lb-298 |
0.432 |
|
| 2014 |
Gu J, He Y, Strom SS, Logothetis CJ, Kim J, Wu X. Abstract 5547: A genetic variant nearKLK3gene is associated with aggressive prostate cancer and can stratify Gleason score 7 patients Cancer Research. 74: 5547-5547. DOI: 10.1158/1538-7445.Am2014-5547 |
0.442 |
|
| 2014 |
Wagner KW, Alam H, Dhar SS, Giri U, Li N, Wei Y, Cascone T, Giri D, Kim J, Ye Y, Multani A, Chan C, Erez B, Saigal B, Lin H, ... Wu X, et al. Abstract 5146: The histone demethylase KDM2A is a new promoter of tumorigenesis, drug target and negative prognostic biomarker for non-small cell lung cancer Cancer Research. 74: 5146-5146. DOI: 10.1158/1538-7445.Am2014-5146 |
0.377 |
|
| 2014 |
Hildebrandt MAT, Ye Y, Zhou Y, Orlowski R, Wu X. Abstract 5077: Common, germline genetic variants within the Wnt/beta-catenin stem cell pathway as determinants of multiple myeloma risk Cancer Research. 74: 5077-5077. DOI: 10.1158/1538-7445.Am2014-5077 |
0.439 |
|
| 2014 |
Lian J, Lin S, Luo S, Huang M, Gu J, Kamat AM, Dinney CP, Wu X. Abstract 5062: Serum microRNA profiling in non-muscle invasive bladder cancer Cancer Research. 74: 5062-5062. DOI: 10.1158/1538-7445.Am2014-5062 |
0.392 |
|
| 2014 |
Pierzynski JA, Hildebrandt M, Ye Y, Rodriguez A, Wu X. Abstract 5045: Genetic and social determinants of quality of life in lung cancer patients Cancer Research. 74: 5045-5045. DOI: 10.1158/1538-7445.Am2014-5045 |
0.416 |
|
| 2014 |
Han L, Zhao H, Strom S, Daniel CR, Chang D, Zhang H, Ye Y, Gu J, Chow W, Wu X. Abstract 5038: Telomere length linking social contexts and cancer risk in Mexican Americans Cancer Research. 74: 5038-5038. DOI: 10.1158/1538-7445.Am2014-5038 |
0.425 |
|
| 2014 |
Majumdar A, Chen J, Lin SH, Katz L, Raju GS, Shetty K, White J, Wu X, Rashid A, McMurray JS, Shaw KR, Su X, Weston B, Thirumurthi S, He AR, et al. Abstract 4703: Genome & exome analysis of early colon cancers reveals new targets Cancer Research. 74: 4703-4703. DOI: 10.1158/1538-7445.Am2014-4703 |
0.338 |
|
| 2014 |
Wang X, Melkonian S, Gu J, Chang D, Tannir N, Wood C, Wu X. Abstract 4320: Mitochondrial DNA copy number in peripheral blood and the risk of clear-cell renal cell carcinoma: Effect of age, gender, smoking, and history of hypertension Cancer Research. 74: 4320-4320. DOI: 10.1158/1538-7445.Am2014-4320 |
0.392 |
|
| 2014 |
Wassenaar CA, Ye Y, Cai Q, Aldrich M, Knight J, Spitz MR, Wu X, Blot WJ, Tyndale RF. Abstract 4149: Genetic variation in CYP2A6, a nicotine/nitrosamine metabolism enzyme, influences lung cancer risk in two independent case-control studies of African American smokers Cancer Research. 74: 4149-4149. DOI: 10.1158/1538-7445.Am2014-4149 |
0.504 |
|
| 2014 |
Sun Y, Stroehlein J, Ajani J, Chang D, Wu X, Gu J. Abstract 3850: Genetic and intermediate phenotypic susceptibility markers of gastric cancer in Hispanic-Americans: A case control study Cancer Research. 74: 3850-3850. DOI: 10.1158/1538-7445.Am2014-3850 |
0.473 |
|
| 2014 |
Lin S, Lian J, Ye Y, Dinney CP, Wu X. Abstract 3827: Predictions for recurrence of non-muscle invasive bladder cancers by circulating miRNAs Cancer Research. 74: 3827-3827. DOI: 10.1158/1538-7445.Am2014-3827 |
0.346 |
|
| 2014 |
Ye Y, Wang Y, Roth J, Wu X. Abstract 298: Serum MicroRNAs as biomarkers in early stage non-small cell lung cancer Cancer Research. 74: 298-298. DOI: 10.1158/1538-7445.Am2014-298 |
0.368 |
|
| 2014 |
Zhang F, Meng QH, Ye Y, Hildebrandt MA, Huang M, Wu X. Abstract 296: Pre-treatment clinical laboratory tests indicative of metabolic status are associated with survival in patients with non-small cell lung cancer Cancer Research. 74: 296-296. DOI: 10.1158/1538-7445.Am2014-296 |
0.406 |
|
| 2014 |
Pu X, Gu J, Ye Y, Ajani J, Wu X. Abstract 2915: Circulating miRNAs as potential biomarkers for esophageal adenocarcinoma risk and clinical outcomes Cancer Research. 74: 2915-2915. DOI: 10.1158/1538-7445.Am2014-2915 |
0.338 |
|
| 2014 |
Sanchez-Espiridion B, Liang D, Ajani JA, Liang S, Ye Y, Hildebrandt MA, Gu J, Wu X. Abstract 2486: Global metabolic profiling identifies novel serum markers for esophageal adenocarcinoma Cancer Research. 74: 2486-2486. DOI: 10.1158/1538-7445.Am2014-2486 |
0.381 |
|
| 2014 |
Stephanie M, Daniel CR, Hildebrandt M, Tannir N, Ye Y, Chow W, Wood C, Wu X. Abstract 1262: Established genetic variants and dietary patterns jointly impact risk of renal cell carcinoma in non-Hispanic whites Cancer Research. 74: 1262-1262. DOI: 10.1158/1538-7445.Am2014-1262 |
0.423 |
|
| 2013 |
de Maturana EL, Ye Y, Calle ML, Rothman N, Urrea V, Kogevinas M, Petrus S, Chanock SJ, Tardón A, GarcÃa-Closas M, González-Neira A, Vellalta G, Carrato A, Navarro A, Lorente-Galdós B, ... ... Wu X, et al. Application of multi-SNP approaches Bayesian LASSO and AUC-RF to detect main effects of inflammatory-gene variants associated with bladder cancer risk. Plos One. 8: e83745. PMID 24391818 DOI: 10.1371/Journal.Pone.0083745 |
0.515 |
|
| 2013 |
Wagner KW, Alam H, Dhar SS, Giri U, Li N, Wei Y, Giri D, Cascone T, Kim JH, Ye Y, Multani AS, Chan CH, Erez B, Saigal B, Chung J, ... ... Wu X, et al. KDM2A promotes lung tumorigenesis by epigenetically enhancing ERK1/2 signaling. The Journal of Clinical Investigation. 123: 5231-46. PMID 24200691 DOI: 10.1172/Jci68642 |
0.329 |
|
| 2013 |
Guo C, Lu H, Gao W, Wang L, Lu K, Wu S, Pataer A, Huang M, El-Zein R, Lin T, Roth JA, Mehran R, Hofstetter W, Swisher SG, Wu X, et al. Insulin-like growth factor binding protein-2 level is increased in blood of lung cancer patients and associated with poor survival. Plos One. 8: e74973. PMID 24069370 DOI: 10.1371/Journal.Pone.0074973 |
0.42 |
|
| 2013 |
Fernández MI, Gong Y, Ye Y, Lin J, Chang DW, Kamat AM, Wu X. γ-H2AX level in peripheral blood lymphocytes as a risk predictor for bladder cancer. Carcinogenesis. 34: 2543-7. PMID 23946494 DOI: 10.1093/Carcin/Bgt270 |
0.46 |
|
| 2013 |
Xu E, Gong Y, Gu J, Jie L, Ajani JA, Wu X. Risk assessment of esophageal adenocarcinoma using γ-H2AX assay. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 22: 1797-804. PMID 23904462 DOI: 10.1158/1055-9965.Epi-13-0485 |
0.416 |
|
| 2013 |
Gu J, Wu X. Re: short telomere length, cancer survival, and cancer risk in 47 102 individuals. Journal of the National Cancer Institute. 105: 1157. PMID 23868923 DOI: 10.1093/Jnci/Djt154 |
0.464 |
|
| 2013 |
Xu E, Sun W, Gu J, Chow WH, Ajani JA, Wu X. Association of mitochondrial DNA copy number in peripheral blood leukocytes with risk of esophageal adenocarcinoma. Carcinogenesis. 34: 2521-4. PMID 23803692 DOI: 10.1093/Carcin/Bgt230 |
0.377 |
|
| 2013 |
Wang Y, Gu J, Roth JA, Hildebrandt MA, Lippman SM, Ye Y, Minna JD, Wu X. Pathway-based serum microRNA profiling and survival in patients with advanced stage non-small cell lung cancer. Cancer Research. 73: 4801-9. PMID 23774211 DOI: 10.1158/0008-5472.Can-12-3273 |
0.376 |
|
| 2013 |
Wu X, Wang L, Ye Y, Aakre JA, Pu X, Chang GC, Yang PC, Roth JA, Marks RS, Lippman SM, Chang JY, Lu C, Deschamps C, Su WC, Wang WC, et al. Genome-wide association study of genetic predictors of overall survival for non-small cell lung cancer in never smokers. Cancer Research. 73: 4028-38. PMID 23704207 DOI: 10.1158/0008-5472.Can-12-4033 |
0.464 |
|
| 2013 |
Chung CC, Kanetsky PA, Wang Z, Hildebrandt MA, Koster R, Skotheim RI, Kratz CP, Turnbull C, Cortessis VK, Bakken AC, Bishop DT, Cook MB, Erickson RL, Fosså SD, Jacobs KB, ... ... Wu X, et al. Meta-analysis identifies four new loci associated with testicular germ cell tumor. Nature Genetics. 45: 680-5. PMID 23666239 DOI: 10.1038/Ng.2634 |
0.395 |
|
| 2013 |
Wang J, Wu X, Kamat A, Grossman HB, Dinney CP, Lin J. Fluid intake, genetic variants of UDP-glucuronosyltransferases, and bladder cancer risk British Journal of Cancer. 108: 2372-2380. PMID 23632476 DOI: 10.1038/Bjc.2013.190 |
0.509 |
|
| 2013 |
Pickering CR, Zhang J, Yoo SY, Bengtsson L, Moorthy S, Neskey DM, Zhao M, Ortega Alves MV, Chang K, Drummond J, Cortez E, Xie TX, Zhang D, Chung W, Issa JP, ... ... Wu X, et al. Integrative genomic characterization of oral squamous cell carcinoma identifies frequent somatic drivers. Cancer Discovery. 3: 770-81. PMID 23619168 DOI: 10.1158/2159-8290.Cd-12-0537 |
0.339 |
|
| 2013 |
Monda KL, Chen GK, Taylor KC, Palmer C, Edwards TL, Lange LA, Ng MC, Adeyemo AA, Allison MA, Bielak LF, Chen G, Graff M, Irvin MR, Rhie SK, Li G, ... ... Wu X, et al. A meta-analysis identifies new loci associated with body mass index in individuals of African ancestry. Nature Genetics. 45: 690-6. PMID 23583978 DOI: 10.1038/Ng.2608 |
0.349 |
|
| 2013 |
Sacerdote C, Guarrera S, Ricceri F, Pardini B, Polidoro S, Allione A, Critelli R, Russo A, Andrew AS, Ye Y, Wu X, Kiemeney LA, Bosio A, Casetta G, Cucchiarale G, et al. Polymorphisms in the XRCC1 gene modify survival of bladder cancer patients treated with chemotherapy. International Journal of Cancer. 133: 2004-9. PMID 23553206 DOI: 10.1002/Ijc.28186 |
0.468 |
|
| 2013 |
Shen H, Fridley BL, Song H, Lawrenson K, Cunningham JM, Ramus SJ, Cicek MS, Tyrer J, Stram D, Larson MC, Köbel M, Ziogas A, Zheng W, Yang HP, ... ... Wu X, et al. Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer. Nature Communications. 4: 1628. PMID 23535649 DOI: 10.1038/Ncomms2629 |
0.497 |
|
| 2013 |
Lee EK, Ye Y, Kamat AM, Wu X. Genetic variations in regulator of G-protein signaling (RGS) confer risk of bladder cancer. Cancer. 119: 1643-51. PMID 23529717 DOI: 10.1002/Cncr.27871 |
0.542 |
|
| 2013 |
Zhang X, Huang M, Wu X, Kadlubar S, Lin J, Yu X, Fan C, Ning B, Kadlubar FF. GSTM1 copy number and promoter haplotype as predictors for risk of recurrence and/or second primary tumor in patients with head and neck cancer. Pharmacogenomics and Personalized Medicine. 6: 9-17. PMID 23526580 DOI: 10.2147/Pgpm.S35949 |
0.427 |
|
| 2013 |
Schumacher FR, Wang Z, Skotheim RI, Koster R, Chung CC, Hildebrandt MA, Kratz CP, Bakken AC, Bishop DT, Cook MB, Erickson RL, Fosså SD, Greene MH, Jacobs KB, Kanetsky PA, ... ... Wu X, et al. Testicular germ cell tumor susceptibility associated with the UCK2 locus on chromosome 1q23. Human Molecular Genetics. 22: 2748-53. PMID 23462292 DOI: 10.1093/Hmg/Ddt109 |
0.409 |
|
| 2013 |
Spitz MR, Amos CI, Land S, Wu X, Dong Q, Wenzlaff AS, Schwartz AG. Role of selected genetic variants in lung cancer risk in African Americans. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 8: 391-7. PMID 23454887 DOI: 10.1097/Jto.0B013E318283Da29 |
0.519 |
|
| 2013 |
Xie H, Wu X, Wang S, Chang D, Pollock RE, Lev D, Gu J. Long telomeres in peripheral blood leukocytes are associated with an increased risk of soft tissue sarcoma. Cancer. 119: 1885-91. PMID 23408253 DOI: 10.1002/Cncr.27984 |
0.42 |
|
| 2013 |
Pu X, Roth JA, Hildebrandt MA, Ye Y, Wei H, Minna JD, Lippman SM, Wu X. MicroRNA-related genetic variants associated with clinical outcomes in early-stage non-small cell lung cancer patients. Cancer Research. 73: 1867-75. PMID 23378343 DOI: 10.1158/0008-5472.Can-12-0873 |
0.455 |
|
| 2013 |
Swartz MD, Peterson CB, Lupo PJ, Wu X, Forman MR, Spitz MR, Hernandez LM, Vannucci M, Shete S. Investigating multiple candidate genes and nutrients in the folate metabolism pathway to detect genetic and nutritional risk factors for lung cancer. Plos One. 8: e53475. PMID 23372658 DOI: 10.1371/Journal.Pone.0053475 |
0.496 |
|
| 2013 |
Xie H, Lev D, Gong Y, Wang S, Pollock RE, Wu X, Gu J. Reduced mitochondrial DNA copy number in peripheral blood leukocytes increases the risk of soft tissue sarcoma. Carcinogenesis. 34: 1039-43. PMID 23349016 DOI: 10.1093/Carcin/Bgt023 |
0.343 |
|
| 2013 |
Ke HL, Chen M, Ye Y, Hildebrandt MA, Wu WJ, Wei H, Huang M, Chang DW, Dinney CP, Wu X. Genetic variations in micro-RNA biogenesis genes and clinical outcomes in non-muscle-invasive bladder cancer. Carcinogenesis. 34: 1006-11. PMID 23322153 DOI: 10.1093/Carcin/Bgt006 |
0.458 |
|
| 2013 |
He Y, Gong Y, Lin J, Chang DW, Gu J, Roth JA, Wu X. Ionizing radiation-induced γ-H2AX activity in whole blood culture and the risk of lung cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 22: 443-51. PMID 23300022 DOI: 10.1158/1055-9965.Epi-12-0794 |
0.487 |
|
| 2013 |
Walsh KM, Gorlov IP, Hansen HM, Wu X, Spitz MR, Zhang H, Lu EY, Wenzlaff AS, Sison JD, Wei C, Lloyd SM, Chen W, Frazier ML, Seldin MF, Bierut LJ, et al. Fine-mapping of the 5p15.33, 6p22.1-p21.31, and 15q25.1 regions identifies functional and histology-specific lung cancer susceptibility loci in African-Americans. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 22: 251-60. PMID 23221128 DOI: 10.1158/1055-9965.Epi-12-1007-T |
0.415 |
|
| 2013 |
Wilkinson AV, Gabriel KP, Wang J, Bondy ML, Dong Q, Wu X, Shete S, Spitz MR. Sensation-seeking genes and physical activity in youth Genes, Brain and Behavior. 12: 181-188. PMID 23190435 DOI: 10.1111/Gbb.12006 |
0.371 |
|
| 2013 |
Henrion M, Frampton M, Scelo G, Purdue M, Ye Y, Broderick P, Ritchie A, Kaplan R, Meade A, McKay J, Johansson M, Lathrop M, Larkin J, Rothman N, Wang Z, ... ... Wu X, et al. Common variation at 2q22.3 (ZEB2) influences the risk of renal cancer. Human Molecular Genetics. 22: 825-31. PMID 23184150 DOI: 10.1093/Hmg/Dds489 |
0.467 |
|
| 2013 |
Skinner HD, Xu E, Lee JH, Bhutani MS, Weston B, Suzuki A, Hofstetter WL, Komaki R, Ajani JA, Wu X. A validated miRNA expression profile for response to neoadjuvant therapy in esophageal cancer. Journal of Clinical Oncology. 31: 4078-4078. DOI: 10.1200/Jco.2013.31.15_Suppl.4078 |
0.332 |
|
| 2013 |
Kim ES, Ye Y, Vaporciyan AA, Xing J, Huang M, Gu J, Roth JA, Lippman SM, Wu X. Telomere length and recurrence risk after curative resection in women with adenocarcinoma of the lung: A prospective cohort study. Journal of Clinical Oncology. 31: 1532-1532. DOI: 10.1200/Jco.2013.31.15_Suppl.1532 |
0.424 |
|
| 2013 |
Zhang F, Wen CP, Liang D, Skinner H, Gu J, Chow W, Ye Y, Hildebrandt MAT, Pu X, Huang M, Tsai MK, Tsao CK, Wu X. Abstract LB-27: Metabolomic profiling identifies bilirubin as a novel serum marker for lung cancer. Cancer Research. 73. DOI: 10.1158/1538-7445.Am2013-Lb-27 |
0.467 |
|
| 2013 |
Skinner HD, Pu X, Chang J, Lu C, Komaki R, Wu X. Abstract 77: Genetic variations in the stem cell pathway predict for toxicity following radiotherapy in lung cancer. Cancer Research. 73: 77-77. DOI: 10.1158/1538-7445.Am2013-77 |
0.493 |
|
| 2013 |
Chen M, Gu J, Gong Y, Ajani JA, Wu X. Abstract 4857: Short overall telomere length and chromosome 17p-specific telomere length in peripheral blood leukocytes are associated with increased risk of esophageal adenocarcinoma. Cancer Research. 73: 4857-4857. DOI: 10.1158/1538-7445.Am2013-4857 |
0.425 |
|
| 2013 |
Pierzynski JA, Hildebrandt MA, Wu X, Lu KH, Liang D. Abstract 4846: Genetic variants in the Wnt/beta-catenin signaling pathway as indicators of ovarian cancer risk and survival. Cancer Research. 73: 4846-4846. DOI: 10.1158/1538-7445.Am2013-4846 |
0.522 |
|
| 2013 |
Xu E, Lu KH, Hildebrandt MA, Huang M, Wu X, Liang D. Abstract 4843: Genetic variants in Notch signaling pathway and ovarian cancer. Cancer Research. 73: 4843-4843. DOI: 10.1158/1538-7445.Am2013-4843 |
0.512 |
|
| 2013 |
Pu X, Skinner HD, Ye Y, Hildebrandt MA, Chang JY, Lu C, Komaki R, Minna JD, Roth JA, Wu X. Abstract 4582: Genome-wide association study of toxicity following definitive radiotherapy in non-small cell lung cancer patients. Epidemiology. 73: 4582-4582. DOI: 10.1158/1538-7445.Am2013-4582 |
0.425 |
|
| 2013 |
Pu X, Wang L, Hildebrandt MA, Ye Y, Chang JY, Lu C, Skinner HD, Niu N, Jenkins GD, Komaki R, Minna JD, Roth JA, Weinshilboum RM, Wu X. Abstract 3626: Inflammation-related genetic variants predict radiation-induced toxicity following definitive radiotherapy for non-small cell lung cancer. Cancer Research. 73: 3626-3626. DOI: 10.1158/1538-7445.Am2013-3626 |
0.482 |
|
| 2013 |
Ye Y, Ajani J, Wu X. Abstract 2571: Genetic variations in telomere maintenance pathway genes are associated with risk of esophageal cancer. Cancer Research. 73: 2571-2571. DOI: 10.1158/1538-7445.Am2013-2571 |
0.538 |
|
| 2013 |
Sanchez-Espiridion B, Gu J, Chang DW, Chang JY, Lu C, Roth JA, Wu X. Abstract 2554: Constitutive short telomere length and lung cancer risk: a large case- control study. Cancer Research. 73: 2554-2554. DOI: 10.1158/1538-7445.Am2013-2554 |
0.472 |
|
| 2013 |
Shu X, Lu C, Chang JY, Roth JA, Wu X. Abstract 1350: Genetic variations in apoptosis pathway are associated with survival in late stage non-small cell lung cancer. Cancer Research. 73: 1350-1350. DOI: 10.1158/1538-7445.Am2013-1350 |
0.505 |
|
| 2013 |
Wang Y, Ajani JA, Ye Y, Huang M, Wu X. Abstract 1349: Genetic variants in DNA repair pathway genes are associated with the risk of esophageal adenocarcinoma. Cancer Research. 73: 1349-1349. DOI: 10.1158/1538-7445.Am2013-1349 |
0.488 |
|
| 2013 |
D'Amelio A, Nguyen CH, El-Zein R, Spitz MR, Wu X, Etzel CJ. Abstract 1345: Evidence for genetic mediation of lung cancer through hay fever. Cancer Research. 73: 1345-1345. DOI: 10.1158/1538-7445.Am2013-1345 |
0.486 |
|
| 2013 |
Fung C, Trent K, Joyce S, Zhou P, Nukui T, Weeks DE, Diergaarde B, Ye Y, Wu X, Yuan J, Grandis J, Weissfeld JL, Romkes M, Egloff AM. Abstract 1340: Identification of epidermal growth factor receptor (EGFR) polymorphisms that modify risk for squamous cell carcinoma of the head and neck (HNSCC). Cancer Research. 73: 1340-1340. DOI: 10.1158/1538-7445.Am2013-1340 |
0.433 |
|
| 2013 |
Fernandez MI, Gong Y, Ye Y, Lin J, Chang D, Wu X. Abstract 113: Gamma-H2AX level in peripheral blood lymphocytes as a risk predictor for bladder cancer. Epidemiology. 73: 113-113. DOI: 10.1158/1538-7445.Am2013-113 |
0.405 |
|
| 2013 |
Henrion M, Frampton M, Scelo G, Purdue M, Ye Y, Broderick P, Ritchie A, Kaplan R, Meade A, McKay J, Johansson M, Lathrop M, Larkin J, Rothman N, Wang Z, ... ... Wu X, et al. Common variation at 2q22.3 (ZEB2) influences the risk of renal cancer[Human Molecular Genetics 22,4 825-831 (2012)]Doi:10.1093/hmg/dds489 Human Molecular Genetics. 22: 2128-2128. DOI: 10.1093/Hmg/Ddt084 |
0.393 |
|
| 2013 |
Fernandez M, Gong Y, Ye Y, Lin J, Chang D, Kamat A, Wu X. 389 Gamma-H2Ax Level In Peripheral Blood Lymphocytes As A Risk Predictor For Bladder Cancer The Journal of Urology. 189. DOI: 10.1016/J.Juro.2013.02.1778 |
0.406 |
|
| 2012 |
Andrew AS, Hu T, Gu J, Gui J, Ye Y, Marsit CJ, Kelsey KT, Schned AR, Tanyos SA, Pendleton EM, Mason RA, Morlock EV, Zens MS, Li Z, Moore JH, ... Wu X, et al. HSD3B and gene-gene interactions in a pathway-based analysis of genetic susceptibility to bladder cancer. Plos One. 7: e51301. PMID 23284679 DOI: 10.1371/Journal.Pone.0051301 |
0.399 |
|
| 2012 |
Wei H, Kamat AM, Aldousari S, Ye Y, Huang M, Dinney CP, Wu X. Genetic variations in the transforming growth factor beta pathway as predictors of bladder cancer risk. Plos One. 7. PMID 23251617 DOI: 10.1371/Journal.Pone.0051758 |
0.524 |
|
| 2012 |
Walsh KM, Amos CI, Wenzlaff AS, Gorlov IP, Sison JD, Wu X, Spitz MR, Hansen HM, Lu EY, Wei C, Zhang H, Chen W, Lloyd SM, Frazier ML, Bracci PM, et al. Association study of nicotinic acetylcholine receptor genes identifies a novel lung cancer susceptibility locus near CHRNA1 in African-Americans. Oncotarget. 3: 1428-38. PMID 23232035 DOI: 10.18632/Oncotarget.746 |
0.507 |
|
| 2012 |
Reyes-Gibby CC, Wang J, Spitz M, Wu X, Yennurajalingam S, Shete S. Genetic variations in interleukin-8 and interleukin-10 are associated with pain, depressed mood, and fatigue in lung cancer patients. Journal of Pain and Symptom Management. 46: 161-72. PMID 23149083 DOI: 10.1016/J.Jpainsymman.2012.07.019 |
0.402 |
|
| 2012 |
Wang J, Spitz MR, Amos CI, Wu X, Wetter DW, Cinciripini PM, Shete S. Method for evaluating multiple mediators: mediating effects of smoking and COPD on the association between the CHRNA5-A3 variant and lung cancer risk. Plos One. 7: e47705. PMID 23077662 DOI: 10.1371/Journal.Pone.0047705 |
0.433 |
|
| 2012 |
Ye Y, Madison B, Wu X, Rustgi AK. A LIN28B polymorphism predicts for colon cancer survival Cancer Biology and Therapy. 13: 1390-1395. PMID 23052130 DOI: 10.4161/Cbt.22336 |
0.345 |
|
| 2012 |
Pu X, Ye Y, Spitz MR, Wang L, Gu J, Lippman SM, Hildebrandt MA, Hong WK, Minna JD, Roth JA, Yang P, Wu X. Predictors of survival in never-smokers with non-small cell lung cancer: a large-scale, two-phase genetic study. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 5983-91. PMID 22977190 DOI: 10.1158/1078-0432.Ccr-12-0774 |
0.353 |
|
| 2012 |
Timofeeva MN, Hung RJ, Rafnar T, Christiani DC, Field JK, Bickeböller H, Risch A, McKay JD, Wang Y, Dai J, Gaborieau V, McLaughlin J, Brenner D, Narod SA, Caporaso NE, ... ... Wu X, et al. Influence of common genetic variation on lung cancer risk: meta-analysis of 14 900 cases and 29 485 controls. Human Molecular Genetics. 21: 4980-95. PMID 22899653 DOI: 10.1093/Hmg/Dds334 |
0.445 |
|
| 2012 |
Ross W, Lynch P, Raju G, Rodriguez A, Burke T, Hafemeister L, Hawk E, Wu X, Dubois RN, Mishra L. Biomarkers, bundled payments, and colorectal cancer care. Genes & Cancer. 3: 16-22. PMID 22893787 DOI: 10.1177/1947601912448958 |
0.384 |
|
| 2012 |
Hartz SM, Short SE, Saccone NL, Culverhouse R, Chen L, Schwantes-An TH, Coon H, Han Y, Stephens SH, Sun J, Chen X, Ducci F, Dueker N, Franceschini N, Frank J, ... ... Wu X, et al. Increased genetic vulnerability to smoking at CHRNA5 in early-onset smokers. Archives of General Psychiatry. 69: 854-60. PMID 22868939 DOI: 10.1001/Archgenpsychiatry.2012.124 |
0.347 |
|
| 2012 |
Kim JY, Hildebrandt MA, Pu X, Ye Y, Correa AM, Vaporciyan AA, Wu X, Roth JA. Variations in the vascular endothelial growth factor pathway predict pulmonary complications. The Annals of Thoracic Surgery. 94: 1079-84; discussion . PMID 22795057 DOI: 10.1016/J.Athoracsur.2012.05.048 |
0.418 |
|
| 2012 |
Chang DW, Gu J, Wu X. Germline prognostic markers for urinary bladder cancer: obstacles and opportunities. Urologic Oncology-Seminars and Original Investigations. 30: 524-532. PMID 22742565 DOI: 10.1016/J.Urolonc.2012.04.003 |
0.459 |
|
| 2012 |
Majumdar A, Curley SA, Wu X, Brown P, Hwang JP, Shetty K, Yao ZX, He AR, Li S, Katz L, Farci P, Mishra L. Hepatic stem cells and transforming growth factor β in hepatocellular carcinoma. Nature Reviews. Gastroenterology & Hepatology. 9: 530-8. PMID 22710573 DOI: 10.1038/Nrgastro.2012.114 |
0.311 |
|
| 2012 |
Wei H, Kamat A, Chen M, Ke HL, Chang DW, Yin J, Grossman HB, Dinney CP, Wu X. Association of polymorphisms in oxidative stress genes with clinical outcomes for bladder cancer treated with Bacillus Calmette-Guérin. Plos One. 7: e38533. PMID 22701660 DOI: 10.1371/Journal.Pone.0038533 |
0.44 |
|
| 2012 |
Lin M, Eng C, Hawk ET, Huang M, Lin J, Gu J, Ellis LM, Wu X. Identification of polymorphisms in ultraconserved elements associated with clinical outcomes in locally advanced colorectal adenocarcinoma. Cancer. 118: 6188-98. PMID 22673945 DOI: 10.1002/Cncr.27653 |
0.378 |
|
| 2012 |
Lin J, Lu C, Stewart DJ, Gu J, Huang M, Chang DW, Lippman SM, Wu X. Systematic evaluation of apoptotic pathway gene polymorphisms and lung cancer risk. Carcinogenesis. 33: 1699-706. PMID 22665367 DOI: 10.1093/Carcin/Bgs192 |
0.45 |
|
| 2012 |
Pilarski R, Patel DA, Weitzel J, McVeigh T, Dorairaj JJ, Heneghan HM, Miller N, Weidhaas JB, Kerin MJ, McKenna M, Wu X, Hildebrandt M, Zelterman D, Sand S, Shulman LP. The KRAS-variant is associated with risk of developing double primary breast and ovarian cancer. Plos One. 7: e37891. PMID 22662244 DOI: 10.1371/Journal.Pone.0037891 |
0.453 |
|
| 2012 |
Lin M, Gu J, Eng C, Ellis LM, Hildebrandt MA, Lin J, Huang M, Calin GA, Wang D, Dubois RN, Hawk ET, Wu X. Genetic polymorphisms in MicroRNA-related genes as predictors of clinical outcomes in colorectal adenocarcinoma patients. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 3982-91. PMID 22661538 DOI: 10.1158/1078-0432.Ccr-11-2951 |
0.405 |
|
| 2012 |
Hildebrandt MA, Lippman SM, Etzel CJ, Kim E, Lee JJ, Khuri FR, Spitz MR, Lotan R, Hong WK, Wu X. Genetic variants in the PI3K/PTEN/AKT/mTOR pathway predict head and neck cancer patient second primary tumor/recurrence risk and response to retinoid chemoprevention. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 3705-13. PMID 22577058 DOI: 10.1158/1078-0432.Ccr-11-3271 |
0.396 |
|
| 2012 |
Spitz MR, Gorlov IP, Dong Q, Wu X, Chen W, Chang DW, Etzel CJ, Caporaso NE, Zhao Y, Christiani DC, Brennan P, Albanes D, Shi J, Thun M, Landi MT, et al. Multistage analysis of variants in the inflammation pathway and lung cancer risk in smokers. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 21: 1213-21. PMID 22573796 DOI: 10.1158/1055-9965.Epi-12-0352-T |
0.469 |
|
| 2012 |
Jacobs KB, Yeager M, Zhou W, Wacholder S, Wang Z, Rodriguez-Santiago B, Hutchinson A, Deng X, Liu C, Horner MJ, Cullen M, Epstein CG, Burdett L, Dean MC, Chatterjee N, ... ... Wu X, et al. Detectable clonal mosaicism and its relationship to aging and cancer. Nature Genetics. 44: 651-8. PMID 22561519 DOI: 10.1038/Ng.2270 |
0.447 |
|
| 2012 |
Dai J, Gu J, Huang M, Eng C, Kopetz ES, Ellis LM, Hawk E, Wu X. GWAS-identified colorectal cancer susceptibility loci associated with clinical outcomes. Carcinogenesis. 33: 1327-31. PMID 22505654 DOI: 10.1093/Carcin/Bgs147 |
0.426 |
|
| 2012 |
Fu YP, Kohaar I, Rothman N, Earl J, Figueroa JD, Ye Y, Malats N, Tang W, Liu L, Garcia-Closas M, Muchmore B, Chatterjee N, Tarway M, Kogevinas M, Porter-Gill P, ... ... Wu X, et al. Common genetic variants in the PSCA gene influence gene expression and bladder cancer risk. Proceedings of the National Academy of Sciences of the United States of America. 109: 4974-9. PMID 22416122 DOI: 10.1073/Pnas.1202189109 |
0.449 |
|
| 2012 |
Chang J, Dinney CP, Huang M, Wu X, Gu J. Genetic variants in telomere-maintenance genes and bladder cancer risk. Plos One. 7: e30665. PMID 22363464 DOI: 10.1371/Journal.Pone.0030665 |
0.518 |
|
| 2012 |
Lin M, Eng C, Hawk ET, Huang M, Greisinger AJ, Gu J, Ellis LM, Wu X, Lin J. Genetic variants within ultraconserved elements and susceptibility to right- and left-sided colorectal adenocarcinoma. Carcinogenesis. 33: 841-7. PMID 22318908 DOI: 10.1093/Carcin/Bgs096 |
0.451 |
|
| 2012 |
VanderWeele TJ, Asomaning K, Tchetgen Tchetgen EJ, Han Y, Spitz MR, Shete S, Wu X, Gaborieau V, Wang Y, McLaughlin J, Hung RJ, Brennan P, Amos CI, Christiani DC, Lin X. Genetic variants on 15q25.1, smoking, and lung cancer: an assessment of mediation and interaction. American Journal of Epidemiology. 175: 1013-20. PMID 22306564 DOI: 10.1093/Aje/Kwr467 |
0.483 |
|
| 2012 |
Hildebrandt MA, Tan W, Tamboli P, Huang M, Ye Y, Lin J, Lee JS, Wood CG, Wu X. Kinome expression profiling identifies IKBKE as a predictor of overall survival in clear cell renal cell carcinoma patients. Carcinogenesis. 33: 799-803. PMID 22266464 DOI: 10.1093/Carcin/Bgs018 |
0.37 |
|
| 2012 |
Lin J, Forman MR, Wang J, Grossman HB, Chen M, Dinney CP, Hawk ET, Wu X. Intake of red meat and heterocyclic amines, metabolic pathway genes and bladder cancer risk. International Journal of Cancer. Journal International Du Cancer. 131: 1892-903. PMID 22261697 DOI: 10.1002/Ijc.27437 |
0.424 |
|
| 2012 |
Wagner KW, Ye Y, Lin J, Vaporciyan AA, Roth JA, Wu X. Genetic variations in epigenetic genes are predictors of recurrence in stage I or II non-small cell lung cancer patients. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 585-92. PMID 22252258 DOI: 10.1158/1078-0432.Ccr-11-2087 |
0.456 |
|
| 2012 |
Kamat AM, Dickstein RJ, Messetti F, Anderson R, Pretzsch SM, Gonzalez GN, Katz RL, Khanna A, Zaidi T, Wu X, Grossman HB, Dinney CP. Use of fluorescence in situ hybridization to predict response to bacillus Calmette-Guérin therapy for bladder cancer: results of a prospective trial. The Journal of Urology. 187: 862-7. PMID 22245325 DOI: 10.1016/J.Juro.2011.10.144 |
0.32 |
|
| 2012 |
Pan JY, Ajani JA, Gu J, Gong Y, Qin A, Quin A, Hung M, Wu X, Izzo JG. Association of Aurora-A (STK15) kinase polymorphisms with clinical outcome of esophageal cancer treated with preoperative chemoradiation. Cancer. 118: 4346-53. PMID 22213102 DOI: 10.1002/Cncr.26581 |
0.499 |
|
| 2012 |
Wilkinson AV, Bondy ML, Wu X, Wang J, Dong Q, D'Amelio AM, Prokhorov AV, Pu X, Yu RK, Etzel CJ, Shete S, Spitz MR. Cigarette experimentation in Mexican origin youth: psychosocial and genetic determinants. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 21: 228-38. PMID 22028400 DOI: 10.1158/1055-9965.Epi-11-0456 |
0.375 |
|
| 2012 |
Wu X, Scelo G, Purdue MP, Rothman N, Johansson M, Ye Y, Wang Z, Zelenika D, Moore LE, Wood CG, Prokhortchouk E, Gaborieau V, Jacobs KB, Chow WH, Toro JR, et al. A genome-wide association study identifies a novel susceptibility locus for renal cell carcinoma on 12p11.23. Human Molecular Genetics. 21: 456-62. PMID 22010048 DOI: 10.1093/Hmg/Ddr479 |
0.463 |
|
| 2012 |
Karp DD, Hanneken JM, Taylor SH, Blumenschein G, Men T, Atkins JT, Pu X, Wu X. Three-Year Survival in Stage IV Non-Small Cell Lung Cancer (NSCLC): The Importance of Metastatic Distribution Journal of Clinical Oncology. 2013: 7608-7608. DOI: 10.4236/Ojts.2013.32009 |
0.386 |
|
| 2012 |
Lin EH, Xiazhen Y, He XC, Wu X, Xie Y, Deng Y, Yang G, Tian Q, Li L. Effect of the ADAPT strategy on dormant CD133+ colon cancer stem cells (CSC) and molecular complete remission measured by peripheral blood mononuclear (PBMC) CD133 mRNA. Journal of Clinical Oncology. 30: e14153-e14153. DOI: 10.1200/Jco.2012.30.15_Suppl.E14153 |
0.315 |
|
| 2012 |
Wu X. Abstract PL05-02: Translational Epidemiology: Towards Personalized Risk Assessment, Prevention, and Therapy Cancer Prevention Research. 5. DOI: 10.1158/1940-6207.Prev-12-Pl05-02 |
0.457 |
|
| 2012 |
Wu X. Abstract CN02-01: Health screening cohort: A new avenue for risk prediction, prevention, and early detection research Cancer Prevention Research. 5. DOI: 10.1158/1940-6207.Prev-12-Cn02-01 |
0.414 |
|
| 2012 |
Pu X, Hildebrandt MAT, Kim JY, Ye Y, Vaporciyan AA, Correa AM, Swisher SG, Roth JA, Wu X. Abstract B91: Genetic variations in the JAK-STAT pathway are associated with postoperative pulmonary complications after lobectomy in lung cancer patients Cancer Prevention Research. 5. DOI: 10.1158/1940-6207.Prev-12-B91 |
0.506 |
|
| 2012 |
Zhang F, Eng C, Lin M, Hildebrandt MAT, He Y, Lin J, Huang M, Gu J, Wu X. Abstract A93: Genetic variations in aging related genes/pathways and colorectal cancer risk Cancer Prevention Research. 5: A93-A93. DOI: 10.1158/1940-6207.Prev-12-A93 |
0.491 |
|
| 2012 |
Chen M, Lin J, Blalock J, Cohen L, Cinciripini PM, Wu X. Abstract A88: Depression and short telomere length increased mortality in bladder cancer patients Cancer Prevention Research. 5: A88-A88. DOI: 10.1158/1940-6207.Prev-12-A88 |
0.367 |
|
| 2012 |
Shu X, Chen M, Ye Y, Huang M, Gu J, Wood CG, Wu X. Abstract A23: Gene set enrichment analysis of renal cell carcinoma genome-wide association data identifies the JAK-STAT pathway mediating susceptibility Cancer Prevention Research. 5: A23-A23. DOI: 10.1158/1940-6207.Prev-12-A23 |
0.409 |
|
| 2012 |
Wen C, Wu X, Yang YC, Tsai MK, Hsu CY. Abstract LB-324: The cancer risks and life shortening effect of low and very low cholesterol among Asians Cancer Research. 72. DOI: 10.1158/1538-7445.Am2012-Lb-324 |
0.399 |
|
| 2012 |
Lin J, Shu X, Kamat A, Hawk ET, Dinney CP, Wu X. Abstract 675: Interplay between dietary trace metal, energy balance, genes in DNA repair pathway and bladder cancer risk Cancer Research. 72: 675-675. DOI: 10.1158/1538-7445.Am2012-675 |
0.393 |
|
| 2012 |
Shu X, Lin J, Wood CG, Tannir NM, Wu X. Abstract 673: Obesity, weight gain, physical activity and polymorphism in mTOR pathway and risk of renal cell carcinoma Cancer Research. 72: 673-673. DOI: 10.1158/1538-7445.Am2012-673 |
0.43 |
|
| 2012 |
Wen C, Lin J, Yang Y, Tsao C, Etzel C, Huang M, Tsai M, Ye Y, Lopa M, Hawk E, Wu X. Abstract 5509: Liver cancer risk prediction model from a large prospective cohort in Taiwan Cancer Research. 72: 5509-5509. DOI: 10.1158/1538-7445.Am2012-5509 |
0.392 |
|
| 2012 |
Czerniak BA, Majewski T, Bondaruk J, Zhang S, Lee S, Baggerly K, Dinney C, Grossman HB, Wu X, Issa J, Zhang W, Gibbs R, Scherer SE. Abstract 5066: Genome sequence and epigenome map of bladder cancer development from occult field effects Cancer Research. 72: 5066-5066. DOI: 10.1158/1538-7445.Am2012-5066 |
0.428 |
|
| 2012 |
Hildebrandt MAT, Pu X, Lippman SM, Wu X. Abstract 4509: Mitochondrial DNA copy number is inversely associated with overall survival in non-small cell lung cancer Cancer Research. 72: 4509-4509. DOI: 10.1158/1538-7445.Am2012-4509 |
0.455 |
|
| 2012 |
Zhang F, Gu J, Gong Y, Hawk E, Ajani JA, Wu X. Abstract 4485: Prediction of esophageal cancer risk through quantification of gamma-H2AX levels in peripheral blood lymphocytes Cancer Research. 72: 4485-4485. DOI: 10.1158/1538-7445.Am2012-4485 |
0.469 |
|
| 2012 |
He Y, Gong Y, Gu J, Lin J, Chang DW, Lippman SM, Roth J, Wu X. Abstract 4484: A novel objective, image-based phenotypic assay reveals higher α-radiation-induced γ-H2AX level in peripheral blood lymphocytes as a risk predictor for lung cancer Cancer Research. 72: 4484-4484. DOI: 10.1158/1538-7445.Am2012-4484 |
0.448 |
|
| 2012 |
Wang Y, Lippman SM, Minna JD, Roth JA, Wu X. Abstract 4149: Pathway-based serum microRNA profiling and late-stage non-small cell lung cancer survival Cancer Research. 72: 4149-4149. DOI: 10.1158/1538-7445.Am2012-4149 |
0.396 |
|
| 2012 |
Ye Y, Dinney CP, Kamat AM, Wu X. Abstract 3658: The association of mitochondrial DNA content with bladder cancer risk and outcome Cancer Research. 72: 3658-3658. DOI: 10.1158/1538-7445.Am2012-3658 |
0.492 |
|
| 2012 |
Pu X, Ye Y, Spitz MR, Wang L, Gu J, Lippman SM, Hildebrandt MA, Hong WK, Minna JD, Roth JA, Yang P, Wu X. Abstract 2929: Predictors of survival in never-smokers with non-small cell lung cancer: A large-scale, two-phase genetic study Cancer Research. 72: 2929-2929. DOI: 10.1158/1538-7445.Am2012-2929 |
0.518 |
|
| 2012 |
Wei H, Hildebrandt MA, Gu J, Ye Y, Huang M, Dinney CP, Wu X. Abstract 2650: A combined bioinformatics and GWAS approach identifies a functional 3′UTR insertion/deletion inYES1associated with bladder cancer risk Cancer Research. 72: 2650-2650. DOI: 10.1158/1538-7445.Am2012-2650 |
0.498 |
|
| 2012 |
Kim ES, Ye Y, Vaporciyan AA, Xing J, Huang M, Gu J, Roth JA, Lippman SM, Wu X. Abstract 1728: Genetic variations in epidermal growth factor receptor pathway predict recurrence and response to chemotherapy in early stage non-small cell lung cancer Cancer Research. 72: 1728-1728. DOI: 10.1158/1538-7445.Am2012-1728 |
0.472 |
|
| 2012 |
Chen M, Ye Y, Dinney CP, Wu X. Abstract 1667: Pathway analysis of bladder cancer genome-wide association study identifies several novel pathways involved in bladder cancer development Cancer Research. 72: 1667-1667. DOI: 10.1158/1538-7445.Am2012-1667 |
0.486 |
|
| 2012 |
Prokunina-Olsson L, Fu Y, Tang W, Figueroa J, Kohaar I, Earl J, Silverman D, Wu X, Real F, Rothman N. 755 From Genome-wide Association Studies to Translational Genomics of Bladder Cancer European Journal of Cancer. 48: S179. DOI: 10.1016/S0959-8049(12)71391-6 |
0.351 |
|
| 2011 |
Lin M, Hawk E, Huang M, Lin J, Gu J, Ellis LM, Wu X, Eng C. Identification of polymorphisms in ultraconserved elements (UCEs) associated with clinical outcomes in patients (pts) with stage II/III colorectal cancer (CRC). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 3529. PMID 28020328 DOI: 10.1200/Jco.2011.29.15_Suppl.3529 |
0.354 |
|
| 2011 |
Spitz MR, Gorlov IP, Amos CI, Dong Q, Chen W, Etzel CJ, Gorlova OY, Chang DW, Pu X, Zhang D, Wang L, Cunningham JM, Yang P, Wu X. Variants in inflammation genes are implicated in risk of lung cancer in never smokers exposed to second-hand smoke. Cancer Discovery. 1: 420-9. PMID 22586632 DOI: 10.1158/2159-8290.Cd-11-0080 |
0.443 |
|
| 2011 |
Wei C, Han Y, Spitz MR, Wu X, Chancoco H, Akiva P, Rechavi G, Brand H, Wun I, Frazier ML, Amos CI. A case-control study of a sex-specific association between a 15q25 variant and lung cancer risk. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 20: 2603-9. PMID 22028403 DOI: 10.1158/1055-9965.Epi-11-0749 |
0.491 |
|
| 2011 |
Yin J, Lu K, Lin J, Wu L, Hildebrandt MA, Chang DW, Meyer L, Wu X, Liang D. Genetic variants in TGF-β pathway are associated with ovarian cancer risk. Plos One. 6: e25559. PMID 21984931 DOI: 10.1371/Journal.Pone.0025559 |
0.506 |
|
| 2011 |
Yin J, Lu C, Gu J, Lippman SM, Hildebrandt MA, Lin J, Stewart D, Spitz MR, Wu X. Common genetic variants in cell cycle pathway are associated with survival in stage III-IV non-small-cell lung cancer. Carcinogenesis. 32: 1867-71. PMID 21965272 DOI: 10.1093/Carcin/Bgr217 |
0.446 |
|
| 2011 |
Gu J, Wu X. Genetic susceptibility to bladder cancer risk and outcome. Personalized Medicine. 8: 365-374. PMID 21927616 DOI: 10.2217/Pme.11.15 |
0.502 |
|
| 2011 |
Garcia-Closas M, Ye Y, Rothman N, Figueroa JD, Malats N, Dinney CP, Chatterjee N, Prokunina-Olsson L, Wang Z, Lin J, Real FX, Jacobs KB, Baris D, Thun M, De Vivo I, ... ... Wu X, et al. A genome-wide association study of bladder cancer identifies a new susceptibility locus within SLC14A1, a urea transporter gene on chromosome 18q12.3. Human Molecular Genetics. 20: 4282-9. PMID 21824976 DOI: 10.1093/Hmg/Ddr342 |
0.331 |
|
| 2011 |
Hinch AG, Tandon A, Patterson N, Song Y, Rohland N, Palmer CD, Chen GK, Wang K, Buxbaum SG, Akylbekova EL, Aldrich MC, Ambrosone CB, Amos C, Bandera EV, Berndt SI, ... ... Wu X, et al. The landscape of recombination in African Americans. Nature. 476: 170-5. PMID 21775986 DOI: 10.1038/Nature10336 |
0.321 |
|
| 2011 |
Pande M, Spitz MR, Wu X, Gorlov IP, Chen WV, Amos CI. Novel genetic variants in the chromosome 5p15.33 region associate with lung cancer risk. Carcinogenesis. 32: 1493-9. PMID 21771723 DOI: 10.1093/Carcin/Bgr136 |
0.489 |
|
| 2011 |
Dai J, Gu J, Lu C, Lin J, Stewart D, Chang D, Roth JA, Wu X. Genetic variations in the regulator of G-protein signaling genes are associated with survival in late-stage non-small cell lung cancer. Plos One. 6: e21120. PMID 21698121 DOI: 10.1371/Journal.Pone.0021120 |
0.425 |
|
| 2011 |
Chen J, Wu X, Pande M, Amos CI, Killary AM, Sen S, Frazier ML. Susceptibility locus for lung cancer at 15q25.1 is not associated with risk of pancreatic cancer. Pancreas. 40: 872-5. PMID 21697764 DOI: 10.1097/Mpa.0B013E318219Dafe |
0.522 |
|
| 2011 |
Yoon HH, Catalano PJ, Murphy KM, Skaar TC, Philips S, Powell M, Montgomery EA, Hafez MJ, Offer SM, Liu G, Meltzer SJ, Wu X, Forastiere AA, Benson AB, Kleinberg LR, et al. Genetic variation in DNA-repair pathways and response to radiochemotherapy in esophageal adenocarcinoma: a retrospective cohort study of the Eastern Cooperative Oncology Group. Bmc Cancer. 11: 176. PMID 21586140 DOI: 10.1186/1471-2407-11-176 |
0.388 |
|
| 2011 |
Lin M, Stewart DJ, Spitz MR, Hildebrandt MA, Lu C, Lin J, Gu J, Huang M, Lippman SM, Wu X. Genetic variations in the transforming growth factor-beta pathway as predictors of survival in advanced non-small cell lung cancer. Carcinogenesis. 32: 1050-6. PMID 21515830 DOI: 10.1093/Carcin/Bgr067 |
0.45 |
|
| 2011 |
Wu X, Ye Y, Rosell R, Amos CI, Stewart DJ, Hildebrandt MA, Roth JA, Minna JD, Gu J, Lin J, Buch SC, Nukui T, Ramirez Serrano JL, Taron M, Cassidy A, et al. Genome-wide association study of survival in non-small cell lung cancer patients receiving platinum-based chemotherapy. Journal of the National Cancer Institute. 103: 817-25. PMID 21483023 DOI: 10.1093/Jnci/Djr075 |
0.313 |
|
| 2011 |
Gu J, Chen M, Shete S, Amos CI, Kamat A, Ye Y, Lin J, Dinney CP, Wu X. A genome-wide association study identifies a locus on chromosome 14q21 as a predictor of leukocyte telomere length and as a marker of susceptibility for bladder cancer. Cancer Prevention Research (Philadelphia, Pa.). 4: 514-21. PMID 21460395 DOI: 10.1158/1940-6207.Capr-11-0063 |
0.49 |
|
| 2011 |
Lee JJ, Wu X, Hildebrandt MA, Yang H, Khuri FR, Kim E, Gu J, Ye Y, Lotan R, Spitz MR, Hong WK. Global assessment of genetic variation influencing response to retinoid chemoprevention in head and neck cancer patients. Cancer Prevention Research (Philadelphia, Pa.). 4: 185-93. PMID 21292633 DOI: 10.1158/1940-6207.Capr-10-0125 |
0.449 |
|
| 2011 |
Purdue MP, Johansson M, Zelenika D, Toro JR, Scelo G, Moore LE, Prokhortchouk E, Wu X, Kiemeney LA, Gaborieau V, Jacobs KB, Chow WH, Zaridze D, Matveev V, Lubinski J, et al. Genome-wide association study of renal cell carcinoma identifies two susceptibility loci on 2p21 and 11q13.3. Nature Genetics. 43: 60-5. PMID 21131975 DOI: 10.1038/Ng.723 |
0.376 |
|
| 2011 |
Gu J, Ye Y, Spitz MR, Lin J, Kiemeney LA, Xing J, Hildebrandt MA, Ki Hong W, Amos CI, Wu X. A genetic variant near the PMAIP1/Noxa gene is associated with increased bleomycin sensitivity. Human Molecular Genetics. 20: 820-6. PMID 21106707 DOI: 10.1093/Hmg/Ddq509 |
0.434 |
|
| 2011 |
Sigurdson AJ, Jones IM, Wei Q, Wu X, Spitz MR, Stram DA, Gross MD, Huang WY, Wang LE, Gu J, Thomas CB, Reding DJ, Hayes RB, Caporaso NE. Prospective analysis of DNA damage and repair markers of lung cancer risk from the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Carcinogenesis. 32: 69-73. PMID 20929901 DOI: 10.1093/Carcin/Bgq204 |
0.495 |
|
| 2011 |
Pu X, Hildebrandt MA, Lu C, Lin J, Stewart DJ, Ye Y, Gu J, Spitz MR, Wu X. PI3K/PTEN/AKT/mTOR pathway genetic variation predicts toxicity and distant progression in lung cancer patients receiving platinum-based chemotherapy. Lung Cancer (Amsterdam, Netherlands). 71: 82-8. PMID 20447721 DOI: 10.1016/J.Lungcan.2010.04.008 |
0.496 |
|
| 2011 |
Gu J, Chen M, Shete S, Amos CI, Kamat A, Ye Y, Lin J, Dinney CP, Wu X. Abstract LB-424: A genome-wide association study identifies a locus on chromosome 14q21 as a predictor of leukocyte telomere length and as a marker of susceptibility to bladder cancer Cancer Research. 71. DOI: 10.1158/1538-7445.Am2011-Lb-424 |
0.513 |
|
| 2011 |
Stewart DJ, Chang DW, Ye Y, Spitz MR, Lu C, Wu X. Abstract 5475: Wnt pathway pharmacogenetics in lung cancer patients treated with platinum regimens Cancer Research. 71: 5475-5475. DOI: 10.1158/1538-7445.Am2011-5475 |
0.469 |
|
| 2011 |
Wang Y, Lu KH, Lin J, Huang M, Wu X, Liang D. Abstract 4669: Genetic variations in telomere pathway genes and ovarian cancer risk, survival and treatment response Cancer Research. 71: 4669-4669. DOI: 10.1158/1538-7445.Am2011-4669 |
0.443 |
|
| 2011 |
Hildebrandt MA, Roth JA, Vaporciyan AA, Pu X, Ye Y, Correa AM, Kim JY, Swisher SG, Wu X. Abstract 4663: Genetic variation in the p38 signaling pathway as markers for postoperative pulmonary complications in lung cancer patients Cancer Research. 71: 4663-4663. DOI: 10.1158/1538-7445.Am2011-4663 |
0.444 |
|
| 2011 |
Pu X, Spitz MR, Amos C, Ye Y, Hildebrandt MA, Chang D, Lu C, Stewart D, Roth JA, Lippman SM, Christiani D, Wu X. Abstract 4662: Genetic predictors of clinical outcomes for patients with non-small cell lung cancer Cancer Research. 71: 4662-4662. DOI: 10.1158/1538-7445.Am2011-4662 |
0.465 |
|
| 2011 |
Gong Y, Tan W, Lin J, Huang M, Wood CG, Wu X. Abstract 4640: Quantification of gamma-H2AX expression in whole blood culture as a risk predictor for renal cell carcinoma Cancer Research. 71: 4640-4640. DOI: 10.1158/1538-7445.Am2011-4640 |
0.414 |
|
| 2011 |
Chen M, Gu J, Ye Y, Lin J, Chang D, Wu X. Abstract 2745: Genetic determinants of telomere length – a genome wide association study Cancer Research. 71: 2745-2745. DOI: 10.1158/1538-7445.Am2011-2745 |
0.407 |
|
| 2011 |
Kim ES, Vaporciyan AA, Xing J, Huang M, Gu J, Roth J, Lippman SM, Wu X. Abstract 2249: Use of telomere length and genetic variations in maintenance genes to predict risk of recurrence and survival in patients with early-stage non-small cell lung cancer Cancer Research. 71: 2249-2249. DOI: 10.1158/1538-7445.Am2011-2249 |
0.501 |
|
| 2011 |
Ye Y, Spitz MR, Yang H, Wu X. Abstract 1174: Genetic variations in microRNA biogenesis pathway genes as susceptibility loci for lung cancer risk Cancer Research. 71: 1174-1174. DOI: 10.1158/1538-7445.Am2011-1174 |
0.532 |
|
| 2011 |
Ke H, Chen M, Dinney CP, Wu X. Abstract 1150: Genetic variations in microRNA-related genes as predictors for recurrence and progression in patients with non-muscle invasive bladder cancer Cancer Research. 71: 1150-1150. DOI: 10.1158/1538-7445.Am2011-1150 |
0.485 |
|
| 2011 |
Meyer L, Liang D, Lin J, Ye Y, Huang M, Pu X, Lu K, Wu X. Genetic variants in the mammalian target of rapamycin (mTOR) signaling pathway as predictors of clinical response and survival in women with ovarian cancer Gynecologic Oncology. 120. DOI: 10.1016/J.Ygyno.2010.12.058 |
0.359 |
|
| 2011 |
Kamat A, Lee E, Ye Y, Wu X. 1242 GENETIC VARIATIONS IN REGULATOR OF G-PROTEIN SIGNALING GENES AS SUSCEPTIBILITY LOCI FOR BLADDER CANCER Journal of Urology. 185. DOI: 10.1016/J.Juro.2011.02.913 |
0.382 |
|
| 2010 |
Liang D, Meyer L, Chang DW, Lin J, Pu X, Ye Y, Gu J, Wu X, Lu K. Genetic variants in MicroRNA biosynthesis pathways and binding sites modify ovarian cancer risk, survival, and treatment response. Cancer Research. 70: 9765-76. PMID 21118967 DOI: 10.1158/0008-5472.Can-10-0130 |
0.435 |
|
| 2010 |
Chen M, Hildebrandt MA, Clague J, Kamat AM, Picornell A, Chang J, Zhang X, Izzo J, Yang H, Lin J, Gu J, Chanock S, Kogevinas M, Rothman N, Silverman DT, ... ... Wu X, et al. Genetic variations in the sonic hedgehog pathway affect clinical outcomes in non-muscle-invasive bladder cancer. Cancer Prevention Research (Philadelphia, Pa.). 3: 1235-45. PMID 20858759 DOI: 10.1158/1940-6207.Capr-10-0035 |
0.47 |
|
| 2010 |
Zhang X, Yang H, Lee JJ, Kim E, Lippman SM, Khuri FR, Spitz MR, Lotan R, Hong WK, Wu X. MicroRNA-related genetic variations as predictors for risk of second primary tumor and/or recurrence in patients with early-stage head and neck cancer. Carcinogenesis. 31: 2118-23. PMID 20819778 DOI: 10.1093/Carcin/Bgq177 |
0.463 |
|
| 2010 |
Hildebrandt MA, Komaki R, Liao Z, Gu J, Chang JY, Ye Y, Lu C, Stewart DJ, Minna JD, Roth JA, Lippman SM, Cox JD, Hong WK, Spitz MR, Wu X. Genetic variants in inflammation-related genes are associated with radiation-induced toxicity following treatment for non-small cell lung cancer. Plos One. 5: e12402. PMID 20811626 DOI: 10.1371/Journal.Pone.0012402 |
0.478 |
|
| 2010 |
Lin J, Horikawa Y, Tamboli P, Clague J, Wood CG, Wu X. Genetic variations in microRNA-related genes are associated with survival and recurrence in patients with renal cell carcinoma Carcinogenesis. 31: 1805-1812. PMID 20732906 DOI: 10.1093/Carcin/Bgq168 |
0.42 |
|
| 2010 |
Hildebrandt MAT, Gu J, Lin J, Ye Y, Tan W, Tamboli P, Wood CG, Wu X. Hsa-miR-9 methylation status is associated with cancer development and metastatic recurrence in patients with clear cell renal cell carcinoma Oncogene. 29: 5724-5728. PMID 20676129 DOI: 10.1038/Onc.2010.305 |
0.336 |
|
| 2010 |
Gu J, Ajani JA, Hawk ET, Ye Y, Lee JH, Bhutani MS, Hofstetter WL, Swisher SG, Wang KK, Wu X. Genome-wide catalogue of chromosomal aberrations in barrett's esophagus and esophageal adenocarcinoma: a high-density single nucleotide polymorphism array analysis. Cancer Prevention Research (Philadelphia, Pa.). 3: 1176-86. PMID 20651033 DOI: 10.1158/1940-6207.Capr-09-0265 |
0.323 |
|
| 2010 |
Wang J, Lippman SM, Lee JJ, Yang H, Khuri FR, Kim E, Lin J, Chang DW, Lotan R, Hong WK, Wu X. Genetic variations in regulator of G-protein signaling genes as susceptibility loci for second primary tumor/recurrence in head and neck squamous cell carcinoma. Carcinogenesis. 31: 1755-61. PMID 20627871 DOI: 10.1093/Carcin/Bgq138 |
0.464 |
|
| 2010 |
Liu Y, Shete S, Wang LE, El-Zein R, Etzel CJ, Liang FW, Armstrong G, Tsavachidis S, Gilbert MR, Aldape KD, Xing J, Wu X, Wei Q, Bondy ML. Gamma-radiation sensitivity and polymorphisms in RAD51L1 modulate glioma risk. Carcinogenesis. 31: 1762-9. PMID 20610542 DOI: 10.1093/Carcin/Bgq141 |
0.414 |
|
| 2010 |
Svatek RS, Shah JB, Xing J, Chang D, Lin J, McConkey DJ, Wu X, Dinney CP. A multiplexed, particle-based flow cytometric assay identified plasma matrix metalloproteinase-7 to be associated with cancer-related death among patients with bladder cancer. Cancer. 116: 4513-9. PMID 20572047 DOI: 10.1002/Cncr.25401 |
0.353 |
|
| 2010 |
Wang J, Spitz MR, Amos CI, Wilkinson AV, Wu X, Shete S. Mediating effects of smoking and chronic obstructive pulmonary disease on the relation between the CHRNA5-A3 genetic locus and lung cancer risk. Cancer. 116: 3458-62. PMID 20564069 DOI: 10.1002/Cncr.25085 |
0.453 |
|
| 2010 |
Amos CI, Gorlov IP, Dong Q, Wu X, Zhang H, Lu EY, Scheet P, Greisinger AJ, Mills GB, Spitz MR. Nicotinic acetylcholine receptor region on chromosome 15q25 and lung cancer risk among African Americans: a case-control study. Journal of the National Cancer Institute. 102: 1199-205. PMID 20554942 DOI: 10.1093/Jnci/Djq232 |
0.516 |
|
| 2010 |
Truong T, Hung RJ, Amos CI, Wu X, Bickeböller H, Rosenberger A, Sauter W, Illig T, Wichmann HE, Risch A, Dienemann H, Kaaks R, Yang P, Jiang R, Wiencke JK, et al. Replication of lung cancer susceptibility loci at chromosomes 15q25, 5p15, and 6p21: a pooled analysis from the International Lung Cancer Consortium. Journal of the National Cancer Institute. 102: 959-71. PMID 20548021 DOI: 10.1093/Jnci/Djq178 |
0.511 |
|
| 2010 |
Chen M, Gu J, Delclos GL, Killary AM, Fan Z, Hildebrandt MA, Chamberlain RM, Grossman HB, Dinney CP, Wu X. Genetic variations of the PI3K-AKT-mTOR pathway and clinical outcome in muscle invasive and metastatic bladder cancer patients. Carcinogenesis. 31: 1387-91. PMID 20530239 DOI: 10.1093/Carcin/Bgq110 |
0.427 |
|
| 2010 |
Saeki N, Gu J, Yoshida T, Wu X. Prostate stem cell antigen: a Jekyll and Hyde molecule? Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 3533-8. PMID 20501618 DOI: 10.1158/1078-0432.Ccr-09-3169 |
0.38 |
|
| 2010 |
Liu P, Yang P, Wu X, Vikis HG, Lu Y, Wang Y, Schwartz AG, Pinney SM, de Andrade M, Gazdar A, Gaba C, Mandal D, Lee J, Kupert E, Seminara D, et al. A second genetic variant on chromosome 15q24-25.1 associates with lung cancer. Cancer Research. 70: 3128-35. PMID 20395203 DOI: 10.1158/0008-5472.Can-09-3583 |
0.511 |
|
| 2010 |
Lin J, Wang J, Greisinger AJ, Grossman HB, Forman MR, Dinney CP, Hawk ET, Wu X. Energy balance, the PI3K-AKT-mTOR pathway genes, and the risk of bladder cancer. Cancer Prevention Research (Philadelphia, Pa.). 3: 505-17. PMID 20354165 DOI: 10.1158/1940-6207.Capr-09-0263 |
0.449 |
|
| 2010 |
Li Y, Sheu CC, Ye Y, de Andrade M, Wang L, Chang SC, Aubry MC, Aakre JA, Allen MS, Chen F, Cunningham JM, Deschamps C, Jiang R, Lin J, Marks RS, ... ... Wu X, et al. Genetic variants and risk of lung cancer in never smokers: a genome-wide association study. The Lancet. Oncology. 11: 321-30. PMID 20304703 DOI: 10.1016/S1470-2045(10)70042-5 |
0.413 |
|
| 2010 |
Clague J, Lippman SM, Yang H, Hildebrandt MA, Ye Y, Lee JJ, Wu X. Genetic variation in MicroRNA genes and risk of oral premalignant lesions. Molecular Carcinogenesis. 49: 183-9. PMID 19851984 DOI: 10.1002/Mc.20588 |
0.422 |
|
| 2010 |
Clague J, Cinciripini P, Blalock J, Wu X, Hudmon KS. The D2 dopamine receptor gene and nicotine dependence among bladder cancer patients and controls. Behavior Genetics. 40: 49-58. PMID 19842028 DOI: 10.1007/S10519-009-9301-0 |
0.341 |
|
| 2010 |
Kim ES, Vaporciyan AA, Xing J, Huang M, Spitz MR, Lippman SM, Gu J, Roth JA, Wu X. Use of telomere length in peripheral leukocytes to predict risk of recurrence in patients with early-stage non-small cell lung cancer after curative resection. Journal of Clinical Oncology. 28: 7031-7031. DOI: 10.1200/Jco.2010.28.15_Suppl.7031 |
0.449 |
|
| 2010 |
Wagner KW, Ye Y, Lin J, Vaporciyan AA, Roth JA, Spitz MR, Wu X. Association of genetic variations in DNA-methyltransferases, histone-methyltransferases, and methylated DNA-binding proteins with recurrence and survival in early-stage non-small cell lung cancer treated with surgery alone or surgery and chemotherapy. Journal of Clinical Oncology. 28: 7010-7010. DOI: 10.1200/Jco.2010.28.15_Suppl.7010 |
0.402 |
|
| 2010 |
Gong Y, Gu J, Ajani J, Luo S, Hawk E, Wu X. Abstract B42: Cell-based, genome-wide assessment of chromosome-specific telomere length by quantitative fluorescent in situ hybridization in esophageal adenocarcinoma patients Cancer Prevention Research. 3. DOI: 10.1158/1940-6207.Prev-10-B42 |
0.318 |
|
| 2010 |
Tan W, Hildebrandt MA, Pu X, Huang M, Tamboli P, Wood CG, Wu X. Abstract B29: Role of inflammatory-related gene expression in clear cell renal cell carcinoma Cancer Prevention Research. 3. DOI: 10.1158/1940-6207.Prev-10-B29 |
0.373 |
|
| 2010 |
Chen M, Kamat A, Hildebrandt MAT, Zhang X, Grossman HB, Dinney CP, Wu X. Abstract PR-09: Genetic variations in the sonic hedgehog pathway and clinical outcomes in bladder cancer Cancer Prevention Research. 3. DOI: 10.1158/1940-6207.Prev-09-Pr-09 |
0.509 |
|
| 2010 |
Zhang X, Yang H, Lee JJ, Kim E, Lippman SM, Khuri FR, Spitz MR, Lotan R, Hong WK, Wu X. Abstract PR-03: Genetic variations in microRNA biogenesis genes as predictors for risk of second primary tumor (SPT) and/or recurrence in patients with early‐stage head and neck cancer Cancer Prevention Research. 3. DOI: 10.1158/1940-6207.Prev-09-Pr-03 |
0.506 |
|
| 2010 |
Hildebrandt MAT, Lippman SM, Kim E, Lee JJ, Khuri F, Spitz MR, Lotan R, Hong WK, Wu X. Abstract B94: Pharmacogenetics of retinoid chemoprevention in head and neck cancer patients: Modulation of response by common genetic variation in the mTOR signaling pathway Cancer Prevention Research. 3. DOI: 10.1158/1940-6207.Prev-09-B94 |
0.465 |
|
| 2010 |
Lin J, Wang J, Grossman HB, Forman MR, Dinney CP, Hawk ET, Wu X. Abstract B114: Energy balance, the PI3K‐AKT‐mTOR pathway genes and the risk of bladder cancer Cancer Prevention Research. 3. DOI: 10.1158/1940-6207.Prev-09-B114 |
0.485 |
|
| 2010 |
Wilkinson AV, Etzel CJ, D'Amelio A, Prokhorov AV, Pu X, Wu X, Bondy ML, Spitz MR. Abstract A86: Psychosocial and genetic determinants of cigarette experimentation in Mexican heritage youth Cancer Prevention Research. 3. DOI: 10.1158/1940-6207.Prev-09-A86 |
0.366 |
|
| 2010 |
Pu X, Lu C, Stewart DJ, Gu J, Hildebrandt MAT, Lin J, Lippman SM, Wu X. Abstract A3: MicroRNA‐related polymorphisms are associated with clinical outcomes in early stage non‐small cell lung cancer patients Cancer Prevention Research. 3. DOI: 10.1158/1940-6207.Prev-09-A3 |
0.463 |
|
| 2010 |
Gu J, Ajani JA, Hawk E, Ye Y, Wang KK, Wu X. Abstract A14: Chromosomal aberrations predict malignant progression and treatment response of Barrett's‐related esophageal neoplasia: A genome‐wide high‐density SNP array analysis Cancer Prevention Research. 3. DOI: 10.1158/1940-6207.Prev-09-A14 |
0.332 |
|
| 2010 |
Lin EH, He XC, Yan X, Deng Y, Yeung R, Gu J, Curley S, Haug J, Blau A, Wu X, Tian Q, Li L. Abstract LB-254: Efficiently targeting cancer stem cells requires tactical activation from their dormant state and subsequent exhaustion Cancer Research. 70. DOI: 10.1158/1538-7445.Am10-Lb-254 |
0.385 |
|
| 2010 |
Li Y, Sheu C, Ye Y, Andrade Md, Wang L, Chang S, Aubry M, Aakre J, Allen M, Chen F, Cunningham J, Deschamps C, Jiang R, Lin J, Marks R, ... ... Wu X, et al. Abstract LB-186: Genetic variants and risk of lung cancer in never-smokers: A genome-wide association study Cancer Research. 70. DOI: 10.1158/1538-7445.Am10-Lb-186 |
0.484 |
|
| 2010 |
Chen M, Lerner S, McConkey D, Gu J, Kamat A, Grossman HB, Dinney CP, Wu X. Abstract 894: Genetic variations in the angiogenesis pathway modulate clinical outcomes of bladder cancer Cancer Research. 70: 894-894. DOI: 10.1158/1538-7445.Am10-894 |
0.538 |
|
| 2010 |
Zhang X, Huang M, Wu X, Kadlubar S, Yu X, Caldwell D, Lin J, Ning B, Kadlubar FF. Abstract 885:GSTM1CNV and promoter SNPs are associated with REC/SPT and survival after Retinoid Acid treatment for head and neck cancer Cancer Research. 70: 885-885. DOI: 10.1158/1538-7445.Am10-885 |
0.441 |
|
| 2010 |
Pu X, Lippman SM, Gu J, Xing J, Chang J, Chang D, Spitz MR, Wu X. Abstract 879: Mitochondrial DNA content and its association with lung cancer risk and clinical outcomes Cancer Research. 70: 879-879. DOI: 10.1158/1538-7445.Am10-879 |
0.492 |
|
| 2010 |
Yin J, Wu X, Lu C, Chang J, Hildebrandt M, Stewart D, Spitz MR, Gu J. Abstract 4662: Genetic variations in the cell-cycle pathway and survival of patients with advanced non-small cell lung cancer receiving platinum-based chemotherapy Cancer Research. 70: 4662-4662. DOI: 10.1158/1538-7445.Am10-4662 |
0.455 |
|
| 2010 |
Tan W, Gu J, Hildebrandt M, Huang M, Wistuba II, Roth JA, Spitz MR, Wu X. Abstract 4092: Aberrant miRNA methylation in tumors from surgically resected lung cancer patients and association with survival Cancer Research. 70: 4092-4092. DOI: 10.1158/1538-7445.Am10-4092 |
0.301 |
|
| 2010 |
Gong Y, Lin J, Ye Y, Wu L, Pu X, Wu X, Liang D, Lu K. Abstract 3593: Genetic variants in NER pathway genes and ovarian cancer risk and outcomes Cancer Research. 70: 3593-3593. DOI: 10.1158/1538-7445.Am10-3593 |
0.541 |
|
| 2010 |
Wu L, Lu K, Pu X, Meyer L, Ye Y, Wu X, Liang D. Abstract 2834: Genetic variants in TGFβ pathway genes and ovarian cancer risk Cancer Research. 70: 2834-2834. DOI: 10.1158/1538-7445.Am10-2834 |
0.526 |
|
| 2010 |
Lin J, Wang J, Grossman HB, Chen M, Dinney CP, Wu X. Abstract 2825: Red meat and heterocyclic amine intake, metabolic pathway genes, and bladder cancer risk Cancer Research. 70: 2825-2825. DOI: 10.1158/1538-7445.Am10-2825 |
0.439 |
|
| 2010 |
Ye Y, Lu K, Wu L, Lin J, Pu X, Wu X, Liang D. Abstract 2752: Genetic variants in MMPs genes as predisposition factors for ovarian cancer risk and clinical outcome Cancer Research. 70: 2752-2752. DOI: 10.1158/1538-7445.Am10-2752 |
0.515 |
|
| 2010 |
Kim SM, Kim S, Park ES, Park Y, Cho JY, Buttar NS, Wang KK, Lee JH, Bhutani MS, Wu X, Izzo J, Ajani JA, Lee J. Abstract 2005: The evolutionarily conserved gene expression signatures SPARC and SPP1 are genetic determinants of progression from Barrett's esophagus to esophageal adenocarcinoma Cancer Research. 70: 2005-2005. DOI: 10.1158/1538-7445.Am10-2005 |
0.32 |
|
| 2010 |
Lin M, Hildebrandt M, Stewart D, Lippman SM, Lu C, Spitz MR, Wu X. Abstract 1675: Lung cancer chemotherapy: genetic variations in the transforming growth factor beta pathway as predictors of survival Cancer Research. 70: 1675-1675. DOI: 10.1158/1538-7445.Am10-1675 |
0.478 |
|
| 2010 |
Jayachandran G, Wu X, Coombes K, Wistuba I, Roth J, Ji L. Abstract 1624: Identification and characterization of phospho-ORM-1 as a novel nicotinic acetylcholine receptor (NAChR)-associated protein and a potential serum marker for lung cancer detection Cancer Research. 70: 1624-1624. DOI: 10.1158/1538-7445.Am10-1624 |
0.356 |
|
| 2010 |
Yang P, Jen J, Li Y, Wang L, Andrade Md, Chang SC, Zhang ZF, Christiani DC, Wu X. GPC5 rs2352028 variant and risk of lung cancer in never smokers – Authors' reply Lancet Oncology. 11: 716. DOI: 10.1016/S1470-2045(10)70180-7 |
0.489 |
|
| 2010 |
Horikawa Y, Wood C, Yang H, Gu J, Habuchi T, Wu X. 212 SINGLE NUCLEOTIDE POLYMORPHISMS OF MICRORNA MACHINERY GENES MODIFY THE RISK OF RENAL CELL CARCINOMA Journal of Urology. 183. DOI: 10.1016/J.Juro.2010.02.269 |
0.356 |
|
| 2010 |
Svatek R, Xing J, Chang D, Shah J, Lin J, McConkey D, Wu X, Dinney C. 1713 A MULTIPLEXED, PARTICLE BASED FLOW CYTOMETRIC ASSAY IDENTIFIED MMP7 TO BE ASSOCIATED WITH CANCER RELATED DEATH AMONG PATIENTS WITH BLADDER CANCER Journal of Urology. 183. DOI: 10.1016/J.Juro.2010.02.1560 |
0.389 |
|
| 2009 |
Wu X, Hildebrandt MAT, Chang DW. Genome-wide association studies of bladder cancer risk: a field synopsis of progress and potential applications Cancer and Metastasis Reviews. 28: 269-280. PMID 20016998 DOI: 10.1007/S10555-009-9190-Y |
0.432 |
|
| 2009 |
Cassidy A, Wang W, Wu X, Lin J. Risk of urinary bladder cancer: a case-control analysis of industry and occupation. Bmc Cancer. 9: 443. PMID 20003537 DOI: 10.1186/1471-2407-9-443 |
0.449 |
|
| 2009 |
Chen M, Cassidy A, Gu J, Delclos GL, Zhen F, Yang H, Hildebrandt MA, Lin J, Ye Y, Chamberlain RM, Dinney CP, Wu X. Genetic variations in PI3K-AKT-mTOR pathway and bladder cancer risk. Carcinogenesis. 30: 2047-52. PMID 19875696 DOI: 10.1093/Carcin/Bgp258 |
0.491 |
|
| 2009 |
Reyes-Gibby CC, Spitz MR, Yennurajalingam S, Swartz M, Gu J, Wu X, Bruera E, Shete S. Role of inflammation gene polymorphisms on pain severity in lung cancer patients. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 18: 2636-42. PMID 19773451 DOI: 10.1158/1055-9965.Epi-09-0426 |
0.356 |
|
| 2009 |
Yang H, Gu J, Wang KK, Zhang W, Xing J, Chen Z, Ajani JA, Wu X. MicroRNA expression signatures in Barrett's esophagus and esophageal adenocarcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 5744-52. PMID 19737949 DOI: 10.1158/1078-0432.Ccr-09-0385 |
0.363 |
|
| 2009 |
Stern MC, Lin J, Figueroa JD, Kelsey KT, Kiltie AE, Yuan JM, Matullo G, Fletcher T, Benhamou S, Taylor JA, Placidi D, Zhang ZF, Steineck G, Rothman N, Kogevinas M, ... ... Wu X, et al. Polymorphisms in DNA repair genes, smoking, and bladder cancer risk: findings from the international consortium of bladder cancer. Cancer Research. 69: 6857-64. PMID 19706757 DOI: 10.1158/0008-5472.Can-09-1091 |
0.48 |
|
| 2009 |
Wu X, Ye Y, Kiemeney LA, Sulem P, Rafnar T, Matullo G, Seminara D, Yoshida T, Saeki N, Andrew AS, Dinney CP, Czerniak B, Zhang ZF, Kiltie AE, Bishop DT, et al. Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer. Nature Genetics. 41: 991-5. PMID 19648920 DOI: 10.1038/Ng.421 |
0.359 |
|
| 2009 |
Wu X, Spitz MR, Lee JJ, Lippman SM, Ye Y, Yang H, Khuri FR, Kim E, Gu J, Lotan R, Hong WK. Novel susceptibility loci for second primary tumors/recurrence in head and neck cancer patients: large-scale evaluation of genetic variants. Cancer Prevention Research (Philadelphia, Pa.). 2: 617-24. PMID 19584075 DOI: 10.1158/1940-6207.Capr-09-0025 |
0.462 |
|
| 2009 |
Kiemeney LA, Grotenhuis AJ, Vermeulen SH, Wu X. Genome-wide association studies in bladder cancer: First results and potential relevance Current Opinion in Urology. 19: 540-546. PMID 19553824 DOI: 10.1097/Mou.0B013E32832Eb336 |
0.488 |
|
| 2009 |
Lin J, Kamat A, Gu J, Chen M, Dinney CP, Forman MR, Wu X. Dietary intake of vegetables and fruits and the modification effects of GSTM1 and NAT2 genotypes on bladder cancer risk. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 18: 2090-7. PMID 19549811 DOI: 10.1158/1055-9965.Epi-08-1174 |
0.423 |
|
| 2009 |
Cassidy A, Balsan J, Vesin A, Wu X, Liloglou T, Brambilla C, Timsit JF, Field JK. Cancer diagnosis in first-degree relatives and non-small cell lung cancer risk: results from a multi-centre case-control study in Europe. European Journal of Cancer. 45: 3047-3053. PMID 19482469 DOI: 10.1016/J.Ejca.2009.05.006 |
0.487 |
|
| 2009 |
Hildebrandt MAT, Gu J, Wu X. Pharmacogenomics of platinum-based chemotherapy in NSCLC Expert Opinion On Drug Metabolism & Toxicology. 5: 745-755. PMID 19442035 DOI: 10.1517/17425250902973711 |
0.372 |
|
| 2009 |
Xing J, Ajani JA, Chen M, Izzo J, Lin J, Chen Z, Gu J, Wu X. Constitutive short telomere length of chromosome 17p and 12q but not 11q and 2p is associated with an increased risk for esophageal cancer. Cancer Prevention Research (Philadelphia, Pa.). 2: 459-65. PMID 19401529 DOI: 10.1158/1940-6207.Capr-08-0227 |
0.334 |
|
| 2009 |
Pan J, Lin J, Izzo JG, Liu Y, Xing J, Huang M, Ajani JA, Wu X. Genetic susceptibility to esophageal cancer: the role of the nucleotide excision repair pathway. Carcinogenesis. 30: 785-92. PMID 19270000 DOI: 10.1093/Carcin/Bgp058 |
0.505 |
|
| 2009 |
Clague J, Lin J, Cassidy A, Matin S, Tannir NM, Tamboli P, Wood CG, Wu X. Family history and risk of renal cell carcinoma: results from a case-control study and systematic meta-analysis. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 18: 801-7. PMID 19240244 DOI: 10.1158/1055-9965.Epi-08-0601 |
0.442 |
|
| 2009 |
Clague J, Shao L, Lin J, Chang S, Zhu Y, Wang W, Wood CG, Wu X. Sensitivity to NNKOAc is associated with renal cancer risk. Carcinogenesis. 30: 706-10. PMID 19237609 DOI: 10.1093/Carcin/Bgp045 |
0.391 |
|
| 2009 |
Pu X, Lippman SM, Yang H, Lee JJ, Wu X. Cyclooxygenase-2 gene polymorphisms reduce the risk of oral premalignant lesions. Cancer. 115: 1498-1506. PMID 19197984 DOI: 10.1002/Cncr.24157 |
0.456 |
|
| 2009 |
Papadimitrakopoulou V, Izzo JG, Liu DD, Myers J, Ceron TL, Lewin J, William WN, Atwell A, Lee JJ, Gillenwater A, El-Naggar A, Wu X, Lippman SM, Hittelman WN, Hong WK. Cyclin D1 and cancer development in laryngeal premalignancy patients. Cancer Prevention Research (Philadelphia, Pa.). 2: 14-21. PMID 19139013 DOI: 10.1158/1940-6207.Capr-08-0111 |
0.409 |
|
| 2009 |
Ye Y, Wang KK, Gu J, Yang H, Lin J, Ajani JA, Wu X. Genetic variations in microRNA-related genes are novel susceptibility loci for esophageal cancer risk. Cancer Prevention Research (Philadelphia, Pa.). 1: 460-9. PMID 19138993 DOI: 10.1158/1940-6207.Capr-08-0135 |
0.511 |
|
| 2009 |
Horikawa Y, Wood CG, Yang H, Zhao H, Ye Y, Gu J, Lin J, Habuchi T, Wu X. Single nucleotide polymorphisms of microRNA machinery genes modify the risk of renal cell carcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 7956-62. PMID 19047128 DOI: 10.1158/1078-0432.Ccr-08-1199 |
0.346 |
|
| 2009 |
Izzo JG, Wu X, Wu TT, Huang P, Lee JS, Liao Z, Lee JH, Bhutani MS, Hofstetter W, Maru D, Hung MC, Ajani JA. Therapy-induced expression of NF-kappaB portends poor prognosis in patients with localized esophageal cancer undergoing preoperative chemoradiation. Diseases of the Esophagus : Official Journal of the International Society For Diseases of the Esophagus / I.S.D.E. 22: 127-32. PMID 19021681 DOI: 10.1111/J.1442-2050.2008.00884.X |
0.342 |
|
| 2009 |
Reyes-Gibby CC, El Osta B, Spitz MR, Parsons H, Kurzrock R, Wu X, Shete S, Bruera E. The influence of tumor necrosis factor-alpha -308 G/A and IL-6 -174 G/C on pain and analgesia response in lung cancer patients receiving supportive care. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 17: 3262-7. PMID 18990769 DOI: 10.1158/1055-9965.Epi-08-0125 |
0.31 |
|
| 2009 |
Wu X, Ye Y, Kiemeney LA, Sulem P, Rafnar T, Matullo G, Seminara D, Yoshida T, Saeki N, Andrew AS, Dinney CP, Czerniak B, Zhang Z, Kiltie AE, Bishop DT, et al. Erratum: Corrigendum: Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer Nature Genetics. 41: 1156-1156. DOI: 10.1038/Ng1009-1156A |
0.32 |
|
| 2008 |
Lu C, Ye Y, Clague J, Chang JY, Lippman SM, Stewart DJ, Spitz M, Wu X. Associations between genetic polymorphisms and survival in patients with advanced non-small cell lung cancer (NSCLC) treated with paclitaxel-based therapy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 11107. PMID 27947885 DOI: 10.1200/Jco.2008.26.15_Suppl.11107 |
0.445 |
|
| 2008 |
Spitz MR, Etzel CJ, Dong Q, Amos CI, Wei Q, Wu X, Hong WK. An expanded risk prediction model for lung cancer. Cancer Prevention Research (Philadelphia, Pa.). 1: 250-4. PMID 19138968 DOI: 10.1158/1940-6207.Capr-08-0060 |
0.452 |
|
| 2008 |
Wu X, Ros MM, Gu J, Kiemeney L. Epidemiology and genetic susceptibility to bladder cancer. Bju International. 102: 1207-15. PMID 19035883 DOI: 10.1111/J.1464-410X.2008.07961.X |
0.498 |
|
| 2008 |
Wang Y, Broderick P, Webb E, Wu X, Vijayakrishnan J, Matakidou A, Qureshi M, Dong Q, Gu X, Chen WV, Spitz MR, Eisen T, Amos CI, Houlston RS. Common 5p15.33 and 6p21.33 variants influence lung cancer risk. Nature Genetics. 40: 1407-9. PMID 18978787 DOI: 10.1038/Ng.273 |
0.45 |
|
| 2008 |
Spitz MR, Amos CI, Dong Q, Lin J, Wu X. The CHRNA5-A3 region on chromosome 15q24-25.1 is a risk factor both for nicotine dependence and for lung cancer Journal of the National Cancer Institute. 100: 1552-1556. PMID 18957677 DOI: 10.1093/Jnci/Djn363 |
0.469 |
|
| 2008 |
Wu X, Lu C, Ye Y, Chang J, Yang H, Lin J, Gu J, Hong WK, Stewart D, Spitz MR. Germline genetic variations in drug action pathways predict clinical outcomes in advanced lung cancer treated with platinum-based chemotherapy. Pharmacogenetics and Genomics. 18: 955-65. PMID 18854777 DOI: 10.1097/Fpc.0B013E32830Efdd4 |
0.433 |
|
| 2008 |
Liu P, Vikis HG, Wang D, Lu Y, Wang Y, Schwartz AG, Pinney SM, Yang P, de Andrade M, Petersen GM, Wiest JS, Fain PR, Gazdar A, Gaba C, Rothschild H, ... ... Wu X, et al. Familial aggregation of common sequence variants on 15q24-25.1 in lung cancer. Journal of the National Cancer Institute. 100: 1326-30. PMID 18780872 DOI: 10.1093/Jnci/Djn268 |
0.509 |
|
| 2008 |
Massion PP, Zou Y, Chen H, Jiang A, Coulson P, Amos CI, Wu X, Wistuba II, Wei Q, Shyr Y, Spitz MR. Smoking-related genomic signatures in non-small cell lung cancer. American Journal of Respiratory and Critical Care Medicine. 178: 1164-1172. PMID 18776155 DOI: 10.1164/Rccm.200801-142Oc |
0.379 |
|
| 2008 |
Gu J, Horikawa Y, Chen M, Dinney CP, Wu X. Benzo(a)pyrene Diol Epoxide-Induced Chromosome 9p21 Aberrations Are Associated with Increased Risk of Bladder Cancer Cancer Epidemiology, Biomarkers & Prevention. 17: 2445-2450. PMID 18768515 DOI: 10.1158/1055-9965.Epi-07-2890 |
0.47 |
|
| 2008 |
Margulis V, Lin J, Yang H, Wang W, Wood CG, Wu X. Genetic Susceptibility to Renal Cell Carcinoma: The Role of DNA Double-Strand Break Repair Pathway Cancer Epidemiology, Biomarkers & Prevention. 17: 2366-2373. PMID 18768505 DOI: 10.1158/1055-9965.Epi-08-0259 |
0.418 |
|
| 2008 |
Lin J, Pu X, Wang W, Matin S, Tannir NM, Wood CG, Wu X. Case–control analysis of nucleotide excision repair pathway and the risk of renal cell carcinoma Carcinogenesis. 29: 2112-2119. PMID 18711149 DOI: 10.1093/Carcin/Bgn189 |
0.434 |
|
| 2008 |
Reyes-Gibby CC, Wu X, Spitz M, Kurzrock R, Fisch M, Bruera E, Shete S. Molecular epidemiology, cancer-related symptoms, and cytokines pathway. The Lancet. Oncology. 9: 777-85. PMID 18672213 DOI: 10.1016/S1470-2045(08)70197-9 |
0.455 |
|
| 2008 |
Horikawa Y, Gu J, Wu X. Genetic susceptibility to bladder cancer with an emphasis on gene-gene and gene-environmental interactions. Current Opinion in Urology. 18: 493-8. PMID 18670273 DOI: 10.1097/Mou.0B013E32830B88Ff |
0.341 |
|
| 2008 |
Xing J, Chen M, Wood CG, Lin J, Spitz MR, Ma J, Amos CI, Shields PG, Benowitz NL, Gu J, de Andrade M, Swan GE, Wu X. Mitochondrial DNA content: its genetic heritability and association with renal cell carcinoma. Journal of the National Cancer Institute. 100: 1104-12. PMID 18664653 DOI: 10.1093/Jnci/Djn213 |
0.343 |
|
| 2008 |
Yang H, Lippman SM, Huang M, Lee JJ, Wang W, Spitz MR, Wu X. Genetic polymorphisms in double-strand break DNA repair genes associated with risk of oral premalignant lesions. European Journal of Cancer. 44: 1603-1611. PMID 18579371 DOI: 10.1016/J.Ejca.2008.05.006 |
0.465 |
|
| 2008 |
Liang D, Lin J, Grossman HB, Ma J, Wei B, Dinney CP, Wu X. Plasma vitamins E and A and risk of bladder cancer: A case-control analysis Cancer Causes and Control. 19: 981-992. PMID 18478342 DOI: 10.1007/S10552-008-9165-2 |
0.417 |
|
| 2008 |
Zhu Y, Horikawa Y, Yang H, Wood CG, Habuchi T, Wu X. BPDE induced lymphocytic chromosome 3p deletions may predict renal cell carcinoma risk. The Journal of Urology. 179: 2416-21. PMID 18433782 DOI: 10.1016/J.Juro.2008.01.092 |
0.349 |
|
| 2008 |
Xing J, Stewart DJ, Gu J, Lu C, Spitz MR, Wu X. Expression of methylation-related genes is associated with overall survival in patients with non-small cell lung cancer British Journal of Cancer. 98: 1716-1722. PMID 18414412 DOI: 10.1038/Sj.Bjc.6604343 |
0.426 |
|
| 2008 |
Amos CI, Wu X, Broderick P, Gorlov IP, Gu J, Eisen T, Dong Q, Zhang Q, Gu X, Vijayakrishnan J, Sullivan K, Matakidou A, Wang Y, Mills G, Doheny K, et al. Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nature Genetics. 40: 616-22. PMID 18385676 DOI: 10.1038/Ng.109 |
0.388 |
|
| 2008 |
Yang H, Gu J, Lin X, Grossman HB, Ye Y, Dinney CP, Wu X. Profiling of genetic variations in inflammation pathway genes in relation to bladder cancer predisposition. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 2236-44. PMID 18381966 DOI: 10.1158/1078-0432.Ccr-07-1670 |
0.457 |
|
| 2008 |
Yang H, Dinney CP, Ye Y, Zhu Y, Grossman HB, Wu X. Evaluation of Genetic Variants in MicroRNA-Related Genes and Risk of Bladder Cancer Cancer Research. 68: 2530-2537. PMID 18381463 DOI: 10.1158/0008-5472.Can-07-5991 |
0.502 |
|
| 2008 |
Ye Y, Yang H, Grossman HB, Dinney C, Wu X, Gu J. Genetic variants in cell cycle control pathway confer susceptibility to bladder cancer. Cancer. 112: 2467-74. PMID 18361427 DOI: 10.1002/Cncr.23472 |
0.371 |
|
| 2008 |
Hoque A, Goodman P, Ambrosone CB, Figg WD, Price DK, Kopp W, Wu X, Conroy J, Lehman TA, Santella RM. Extraction of DNA from serum for high-throughput genotyping: findings from pilot studies within the Prostate Cancer Prevention Trial. Urology. 71: 967-70. PMID 18267333 DOI: 10.1016/J.Urology.2007.11.042 |
0.331 |
|
| 2008 |
Zhu Y, Hoffman A, Wu X, Zhang H, Zhang Y, Leaderer D, Zheng T. Correlating observed odds ratios from lung cancer case-control studies to SNP functional scores predicted by bioinformatic tools. Mutation Research. 639: 80-8. PMID 18191955 DOI: 10.1016/J.Mrfmmm.2007.11.005 |
0.416 |
|
| 2008 |
Reyes-Gibby CC, Spitz M, Wu X, Merriman K, Etzel C, Bruera E, Kurzrock R, Shete S. Cytokine genes and pain severity in lung cancer: exploring the influence of TNF-alpha-308 G/A IL6-174G/C and IL8-251T/A. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 16: 2745-51. PMID 18086782 DOI: 10.1158/1055-9965.Epi-07-0651 |
0.374 |
|
| 2008 |
Zhu Y, Yang H, Chen Q, Lin J, Grossman HB, Dinney CP, Wu X, Gu J. Modulation of DNA damage/DNA repair capacity by XPC polymorphisms. Dna Repair. 7: 141-8. PMID 17923445 DOI: 10.1016/J.Dnarep.2007.08.006 |
0.316 |
|
| 2008 |
Amos C, Spitz M, Wu X, Gorlov I. Abstract CN14-01: A genome-wide association study identifies variation in nicotine acetylcholine receptors that influence risk for lung cancer and smoking behavior Cancer Prevention Research. 1. DOI: 10.1158/1940-6207.Prev-08-Cn14-01 |
0.506 |
|
| 2008 |
Wu X. Abstract CN07-02: Personalized prediction of bladder cancer risk: an integrative approach Cancer Prevention Research. 1. DOI: 10.1158/1940-6207.Prev-08-Cn07-02 |
0.493 |
|
| 2008 |
Chen M, Cassidy A, Gu J, Yang H, Lin J, Ye Y, Hildebrandt M, Dinney C, Wu X. Abstract B40: Genetic variations in PI3K-AKT-mTOR pathway and bladder cancer risk Cancer Prevention Research. 1. DOI: 10.1158/1940-6207.Prev-08-B40 |
0.476 |
|
| 2008 |
Hildebrandt M, Tamboli P, Huang M, Ye Y, Lee J, Wu X. Abstract A110: Kinase gene expression profiles are associated with clinical outcomes in clear cell renal cell carcinoma patients Cancer Prevention Research. 1. DOI: 10.1158/1940-6207.Prev-08-A110 |
0.423 |
|
| 2008 |
Clague J, Lin J, Chang J, Hildebrandt M, Izzo J, Yang H, Kamat A, Wu X. Abstract A105: Genetic variations in sonic pathway genes as predictors of bladder cancer risk Cancer Prevention Research. 1. DOI: 10.1158/1940-6207.Prev-08-A105 |
0.519 |
|
| 2008 |
Kader AK, Shao L, Dinney CP, Wang Y, Gu J, Grossman HB, Wu X. ASSOCIATION OF EGFR FAMILY POLYMORPHISMS AND BLADDER CANCER RISK Journal of Urology. 179: 263-263. DOI: 10.1016/S0022-5347(08)60762-4 |
0.466 |
|
| 2008 |
Wu X, Yang H, Lin J, Spitz MR. Lung Cancer Susceptibility and Risk Assessment Models Lung Cancer, Third Edition. 33-60. DOI: 10.1002/9780470696330.ch3 |
0.339 |
|
| 2007 |
Wu X, Lin J, Grossman HB, Huang M, Gu J, Etzel CJ, Amos CI, Dinney CP, Spitz MR. Projecting individualized probabilities of developing bladder cancer in white individuals. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 25: 4974-81. PMID 17971596 DOI: 10.1200/Jco.2007.10.7557 |
0.428 |
|
| 2007 |
Lin J, Swan GE, Shields PG, Benowitz NL, Gu J, Amos CI, de Andrade M, Spitz MR, Wu X. Mutagen sensitivity and genetic variants in nucleotide excision repair pathway: genotype-phenotype correlation. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 16: 2065-71. PMID 17932354 DOI: 10.1158/1055-9965.Epi-06-1041 |
0.429 |
|
| 2007 |
Wang W, Spitz MR, Yang H, Lu C, Stewart DJ, Wu X. Genetic variants in cell cycle control pathway confer susceptibility to lung cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 5974-81. PMID 17908995 DOI: 10.1158/1078-0432.Ccr-07-0113 |
0.53 |
|
| 2007 |
Leibovici D, Kassouf W, Pisters LL, Pettaway CA, Wu X, Dinney CP, Grossman HB. Organ preservation for muscle-invasive bladder cancer by transurethral resection. Urology. 70: 473-476. PMID 17905099 DOI: 10.1016/J.Urology.2007.05.007 |
0.349 |
|
| 2007 |
Saldivar JS, Wu X, Follen M, Gershenson D. Nucleotide excision repair pathway review I: implications in ovarian cancer and platinum sensitivity. Gynecologic Oncology. 107: S56-71. PMID 17884153 DOI: 10.1016/J.Ygyno.2007.07.043 |
0.437 |
|
| 2007 |
Saldivar JS, Lu KH, Liang D, Gu J, Huang M, Vlastos AT, Follen M, Wu X. Moving toward individualized therapy based on NER polymorphisms that predict platinum sensitivity in ovarian cancer patients Gynecologic Oncology. 107: S223-S229. PMID 17825393 DOI: 10.1016/J.Ygyno.2007.07.024 |
0.401 |
|
| 2007 |
Chen M, Kamat AM, Huang M, Grossman HB, Dinney CP, Lerner SP, Wu X, Gu J. High-order interactions among genetic polymorphisms in nucleotide excision repair pathway genes and smoking in modulating bladder cancer risk. Carcinogenesis. 28: 2160-2165. PMID 17728339 DOI: 10.1093/Carcin/Bgm167 |
0.493 |
|
| 2007 |
Shao L, Wood CG, Zhang D, Tannir NM, Matin S, Dinney CP, Wu X. Telomere dysfunction in peripheral lymphocytes as a potential predisposition factor for renal cancer. The Journal of Urology. 178: 1492-6. PMID 17707063 DOI: 10.1016/J.Juro.2007.05.112 |
0.313 |
|
| 2007 |
Lee S, Jeong J, Majewski T, Scherer SE, Kim MS, Tuziak T, Tang KS, Baggerly K, Grossman HB, Zhou JH, Shen L, Bondaruk J, Ahmed SS, Samanta S, Spiess P, ... Wu X, et al. Forerunner genes contiguous to RB1 contribute to the development of in situ neoplasia. Proceedings of the National Academy of Sciences of the United States of America. 104: 13732-7. PMID 17702869 DOI: 10.1073/Pnas.0701771104 |
0.439 |
|
| 2007 |
Xing J, Spitz MR, Lu C, Zhao H, Yang H, Wang W, Stewart DJ, Wu X. Deficient G2-M and S checkpoints are associated with increased lung cancer risk: a case-control analysis. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 16: 1517-22. PMID 17627019 DOI: 10.1158/1055-9965.Epi-07-0111 |
0.332 |
|
| 2007 |
Milam MR, Gu J, Yang H, Celestino J, Wu W, Horwitz IB, Lacour RA, Westin SN, Gershenson DM, Wu X, Lu KH. STK15 F31I polymorphism is associated with increased uterine cancer risk: A pilot study Gynecologic Oncology. 107: 71-74. PMID 17599395 DOI: 10.1016/J.Ygyno.2007.05.025 |
0.527 |
|
| 2007 |
Engels EA, Wu X, Gu J, Dong Q, Liu J, Spitz MR. Systematic evaluation of genetic variants in the inflammation pathway and risk of lung cancer. Cancer Research. 67: 6520-6527. PMID 17596594 DOI: 10.1158/0008-5472.Can-07-0370 |
0.511 |
|
| 2007 |
Jhamb M, Lin J, Ballow R, Kamat AM, Grossman HB, Wu X. Urinary tract diseases and bladder cancer risk: A case-control study Cancer Causes & Control. 18: 839-845. PMID 17593531 DOI: 10.1007/S10552-007-9028-2 |
0.44 |
|
| 2007 |
Yang H, Spitz MR, Stewart DJ, Lu C, Gorlov IP, Wu X. ATM sequence variants associate with susceptibility to non-small cell lung cancer. International Journal of Cancer. Journal International Du Cancer. 121: 2254-9. PMID 17582598 DOI: 10.1002/Ijc.22918 |
0.5 |
|
| 2007 |
Wang Y, Spitz MR, Lee JJ, Huang M, Lippman SM, Wu X. Nucleotide excision repair pathway genes and oral premalignant lesions. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 3753-8. PMID 17575242 DOI: 10.1158/1078-0432.Ccr-06-1911 |
0.444 |
|
| 2007 |
Lin X, Wood CG, Shao L, Huang M, Yang H, Dinney CP, Wu X. Risk assessment of renal cell carcinoma using alkaline comet assay. Cancer. 110: 282-8. PMID 17549681 DOI: 10.1002/Cncr.22792 |
0.395 |
|
| 2007 |
Kader AK, Liu J, Shao L, Dinney CP, Lin J, Wang Y, Gu J, Grossman HB, Wu X. Matrix metalloproteinase polymorphisms are associated with bladder cancer invasiveness. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 2614-20. PMID 17473191 DOI: 10.1158/1078-0432.Ccr-06-1187 |
0.378 |
|
| 2007 |
Spitz MR, Hong WK, Amos CI, Wu X, Schabath MB, Dong Q, Shete S, Etzel CJ. A risk model for prediction of lung cancer. Journal of the National Cancer Institute. 99: 715-26. PMID 17470739 DOI: 10.1093/Jnci/Djk153 |
0.439 |
|
| 2007 |
Wu X, Gu J, Spitz MR. Mutagen sensitivity: A genetic predisposition factor for cancer Cancer Research. 67: 3493-3495. PMID 17440053 DOI: 10.1158/0008-5472.Can-06-4137 |
0.464 |
|
| 2007 |
Kamat AM, Wu X. Statins and the effect of BCG on bladder cancer [23] The New England Journal of Medicine. 356: 1276-1277. PMID 17377172 DOI: 10.1056/Nejmc070117 |
0.416 |
|
| 2007 |
Xing J, Zhu Y, Zhao H, Yang H, Chen M, Spitz MR, Wu X. Differential induction in telomerase activity among bladder cancer patients and controls on gamma-radiation. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 16: 606-9. PMID 17372259 DOI: 10.1158/1055-9965.Epi-06-0615 |
0.468 |
|
| 2007 |
Taioli E, Benhamou S, Bouchardy C, Cascorbi I, Cajas-Salazar N, Dally H, Fong KM, Larsen JE, Le Marchand L, London SJ, Risch A, Spitz MR, Stucker I, Weinshenker B, Wu X, et al. Myeloperoxidase G-463A polymorphism and lung cancer: a HuGE genetic susceptibility to environmental carcinogens pooled analysis. Genetics in Medicine : Official Journal of the American College of Medical Genetics. 9: 67-73. PMID 17304047 DOI: 10.1097/Gim.0B013E31803068B1 |
0.441 |
|
| 2007 |
Zhao H, Lin J, Grossman HB, Hernandez LM, Dinney CP, Wu X. Dietary isothiocyanates, GSTM1, GSTT1, NAT2 polymorphisms and bladder cancer risk. International Journal of Cancer. 120: 2208-13. PMID 17290402 DOI: 10.1002/Ijc.22549 |
0.493 |
|
| 2007 |
Wu X, Lin J, Etzel CJ, Dong Q, Gorlova OY, Zhang Q, Amos CI, Spitz MR. Interplay between mutagen sensitivity and epidemiological factors in modulatinglung cancer risk. International Journal of Cancer. 120: 2687-95. PMID 17290394 DOI: 10.1002/Ijc.22588 |
0.42 |
|
| Show low-probability matches. |